,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,36421,938,Drug Gene Interaction database (DGIdb),Nicotinic acid,,NIACIN,https://www.dgidb.org/drugs/NIACIN,,NNMT,https://www.dgidb.org/genes/NNMT,,,4837.0,NNMT,9606.0,Homo sapiens (human),,,,,,,,
1,36422,938,BindingDB,Nicotinic acid,23515,CHEMBL573,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23515,5298,Nicotinamidase (SpNic),https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5298,,,,,,,,Ki (nM),2000000,PMID:20979384,https://www.ncbi.nlm.nih.gov/pubmed/20979384,20979384,,
2,59474,938,Drug Gene Interaction database (DGIdb),Nicotinic acid,,NIACIN,https://www.dgidb.org/drugs/NIACIN,,QPRT,https://www.dgidb.org/genes/QPRT,,,23475.0,QPRT,9606.0,Homo sapiens (human),,,,,,,,
3,59475,938,Drug Gene Interaction database (DGIdb),Nicotinic acid,,NIACIN,https://www.dgidb.org/drugs/NIACIN,,CYP3A4,https://www.dgidb.org/genes/CYP3A4,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),,,,PMID:22931300,https://www.ncbi.nlm.nih.gov/pubmed/22931300,22931300,,
4,59567,938,Drug Gene Interaction database (DGIdb),Nicotinic acid,,NIACIN,https://www.dgidb.org/drugs/NIACIN,,CYP1A2,https://www.dgidb.org/genes/CYP1A2,,,1544.0,CYP1A2,9606.0,Homo sapiens (human),,,,PMID:22931300,https://www.ncbi.nlm.nih.gov/pubmed/22931300,22931300,,
5,62580,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9986.0,Oryctolagus cuniculus (rabbit),Niacin inhibits the reaction [TNF protein results in increased expression of ICAM1 mrna]|niacin inhibits the reaction [TNF protein results in increased expression of VCAM1 mrna]|niacin inhibits the reaction [TNF protein results in increased expression of CCL2 mrna],,,PMID:20167660,https://www.ncbi.nlm.nih.gov/pubmed/20167660,20167660,,
6,62581,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116.0,Rattus norvegicus (Norway rat),"Niacin inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of TNF protein]|niacin inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of TNF mrna]",,,PMID:20975550,https://www.ncbi.nlm.nih.gov/pubmed/20975550,20975550,,
7,62582,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,10116.0,Rattus norvegicus (Norway rat),Niacin deficiency inhibits the reaction [etoposide results in increased expression of TP53 protein]|niacin deficiency results in decreased expression of TP53 mrna|niacin deficiency affects the expression of TP53 protein,,,PMID:17516866,https://www.ncbi.nlm.nih.gov/pubmed/17516866,17516866,,
8,62583,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,7168,TPM1,https://ctdbase.org/detail.go?type=gene&acc=7168,,,7168.0,TPM1,10090.0,Mus musculus (house mouse),LEPR gene mutant form promotes the reaction [[niacin binds to chromium] which results in increased expression of TPM1 mrna],,,PMID:16940432,https://www.ncbi.nlm.nih.gov/pubmed/16940432,16940432,,
9,62733,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,7274,TTPA,https://ctdbase.org/detail.go?type=gene&acc=7274,,,7274.0,TTPA,10090.0,Mus musculus (house mouse),LEPR gene mutant form promotes the reaction [[niacin binds to chromium] which results in decreased expression of TTPA mrna],,,PMID:16940432,https://www.ncbi.nlm.nih.gov/pubmed/16940432,16940432,,
10,62734,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,7350,UCP1,https://ctdbase.org/detail.go?type=gene&acc=7350,,,7350.0,UCP1,10090.0,Mus musculus (house mouse),LEPR gene mutant form promotes the reaction [[niacin binds to chromium] which results in decreased expression of UCP1 mrna],,,PMID:16940432,https://www.ncbi.nlm.nih.gov/pubmed/16940432,16940432,,
11,62735,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,7412,VCAM1,https://ctdbase.org/detail.go?type=gene&acc=7412,,,7412.0,VCAM1,9606.0,Homo sapiens (human),Niacin inhibits the reaction [TNF protein results in increased expression of VCAM1 mrna],,,PMID:18550065,https://www.ncbi.nlm.nih.gov/pubmed/18550065,18550065,,
12,62736,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,7412,VCAM1,https://ctdbase.org/detail.go?type=gene&acc=7412,,,7412.0,VCAM1,9986.0,Oryctolagus cuniculus (rabbit),Niacin inhibits the reaction [TNF protein results in increased expression of VCAM1 mrna]|niacin results in decreased expression of VCAM1 mRNA,,,PMID:20167660,https://www.ncbi.nlm.nih.gov/pubmed/20167660,20167660,,
13,62737,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422.0,VEGFA,10090.0,Mus musculus (house mouse),Niacin results in increased expression of VEGFA mRNA,,,PMID:17557352,https://www.ncbi.nlm.nih.gov/pubmed/17557352,17557352,,
14,62738,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,7448,VTN,https://ctdbase.org/detail.go?type=gene&acc=7448,,,7448.0,VTN,9606.0,Homo sapiens (human),Niacin results in increased expression of VTN protein,,,PMID:20539903,https://www.ncbi.nlm.nih.gov/pubmed/20539903,20539903,,
15,62739,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,19,ABCA1,https://ctdbase.org/detail.go?type=gene&acc=19,,,19.0,ABCA1,9606.0,Homo sapiens (human),[chromium co-treated with niacin] results in decreased expression of ABCA1 mRNA,,,PMID:18602814,https://www.ncbi.nlm.nih.gov/pubmed/18602814,18602814,,
16,62740,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,19,ABCA1,https://ctdbase.org/detail.go?type=gene&acc=19,,,19.0,ABCA1,9606.0,Homo sapiens (human),Niacin results in increased expression of ABCA1 mRNA,,,PMID:15037193|PMID:18602814,https://www.ncbi.nlm.nih.gov/pubmed/15037193|https://www.ncbi.nlm.nih.gov/pubmed/18602814,15037193|18602814,,
17,62741,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,19,ABCA1,https://ctdbase.org/detail.go?type=gene&acc=19,,,19.0,ABCA1,10090.0,Mus musculus (house mouse),2-chloro-5-nitrobenzanilide inhibits the reaction [niacin results in increased expression of ABCA1 mrna]|niacin results in increased expression of ABCA1 mrna|pparg protein promotes the reaction [niacin results in increased expression of ABCA1 mrna],,,PMID:19797938,https://www.ncbi.nlm.nih.gov/pubmed/19797938,19797938,,
18,62742,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,19,ABCA1,https://ctdbase.org/detail.go?type=gene&acc=19,,,19.0,ABCA1,10090.0,Mus musculus (house mouse),"ABCA1 protein promotes the reaction [niacin results in increased export of cholesterol, HDL]",,,PMID:20448206,https://www.ncbi.nlm.nih.gov/pubmed/20448206,20448206,,
19,62929,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,19,ABCA1,https://ctdbase.org/detail.go?type=gene&acc=19,,,19.0,ABCA1,10090.0,Mus musculus (house mouse),[[niacin binds to and results in increased activity of HCAR2 protein] which results in decreased expression of ABCA1 protein] which results in decreased export of cholesterol|[niacin binds to and results in increased activity of HCAR2 protein] which results in decreased expression of ABCA1 protein,,,PMID:20655299,https://www.ncbi.nlm.nih.gov/pubmed/20655299,20655299,,
20,62930,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,19,ABCA1,https://ctdbase.org/detail.go?type=gene&acc=19,,,19.0,ABCA1,10116.0,Rattus norvegicus (Norway rat),Niacin results in decreased expression of ABCA1 protein,,,PMID:19878707,https://www.ncbi.nlm.nih.gov/pubmed/19878707,19878707,,
21,62931,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,19,ABCA1,https://ctdbase.org/detail.go?type=gene&acc=19,,,19.0,ABCA1,10116.0,Rattus norvegicus (Norway rat),Niacin results in increased expression of ABCA1 mRNA,,,PMID:20303128,https://www.ncbi.nlm.nih.gov/pubmed/20303128,20303128,,
22,62932,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,9619,ABCG1,https://ctdbase.org/detail.go?type=gene&acc=9619,,,9619.0,ABCG1,10090.0,Mus musculus (house mouse),"ABCG1 protein promotes the reaction [niacin results in increased export of cholesterol, HDL]",,,PMID:20448206,https://www.ncbi.nlm.nih.gov/pubmed/20448206,20448206,,
23,62933,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,9619,ABCG1,https://ctdbase.org/detail.go?type=gene&acc=9619,,,9619.0,ABCG1,10090.0,Mus musculus (house mouse),HCAR2 protein inhibits the reaction [[niacin results in increased expression of ABCG1 protein] which results in increased export of cholesterol]|[niacin results in increased expression of ABCG1 protein] which results in increased export of cholesterol|niacin results in increased expression of ABCG1 protein,,,PMID:21317532,https://www.ncbi.nlm.nih.gov/pubmed/21317532,21317532,,
24,62934,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,9619,ABCG1,https://ctdbase.org/detail.go?type=gene&acc=9619,,,9619.0,ABCG1,10116.0,Rattus norvegicus (Norway rat),Niacin results in decreased expression of ABCG1 protein,,,PMID:19878707,https://www.ncbi.nlm.nih.gov/pubmed/19878707,19878707,,
25,62935,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,1636,ACE,https://ctdbase.org/detail.go?type=gene&acc=1636,,,1636.0,ACE,10116.0,Rattus norvegicus (Norway rat),Niacin results in decreased activity of ACE protein,,,PMID:18374418,https://www.ncbi.nlm.nih.gov/pubmed/18374418,18374418,,
26,62936,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,10090.0,Mus musculus (house mouse),Niacin inhibits the reaction [rotenone results in increased expression of ACHE protein]|[curcumin co-treated with niacin co-treated with ZM 241385] inhibits the reaction [rotenone results in increased expression of ACHE protein],,,PMID:31820278,https://www.ncbi.nlm.nih.gov/pubmed/31820278,31820278,,
27,62937,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,130013,ACMSD,https://ctdbase.org/detail.go?type=gene&acc=130013,,,130013.0,ACMSD,10116.0,Rattus norvegicus (Norway rat),[diethylhexyl phthalate results in decreased activity of ACMSD protein] which results in increased abundance of niacin|dibutyl phthalate affects the reaction [ACMSD protein affects the abundance of niacin]|acmsd protein affects the abundance of niacin,,,PMID:12036039,https://www.ncbi.nlm.nih.gov/pubmed/12036039,12036039,,
28,62938,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,6868,ADAM17,https://ctdbase.org/detail.go?type=gene&acc=6868,,,6868.0,ADAM17,10116.0,Rattus norvegicus (Norway rat),Niacin results in increased expression of ADAM17 protein,,,PMID:19223914,https://www.ncbi.nlm.nih.gov/pubmed/19223914,19223914,,
29,63107,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,9370,ADIPOQ,https://ctdbase.org/detail.go?type=gene&acc=9370,,,9370.0,ADIPOQ,9606.0,Homo sapiens (human),Niacin promotes the reaction [ADIPOQ protein binds to ADIPOQ protein],,,PMID:17996241|PMID:18249215,https://www.ncbi.nlm.nih.gov/pubmed/17996241|https://www.ncbi.nlm.nih.gov/pubmed/18249215,17996241|18249215,,
30,63108,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,9370,ADIPOQ,https://ctdbase.org/detail.go?type=gene&acc=9370,,,9370.0,ADIPOQ,9606.0,Homo sapiens (human),Niacin results in increased expression of ADIPOQ mRNA,,,PMID:19131065,https://www.ncbi.nlm.nih.gov/pubmed/19131065,19131065,,
31,63109,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,9370,ADIPOQ,https://ctdbase.org/detail.go?type=gene&acc=9370,,,9370.0,ADIPOQ,9606.0,Homo sapiens (human),Niacin results in increased expression of ADIPOQ protein,,,PMID:16887123|PMID:16979396|PMID:17996241|PMID:18249215|PMID:19131065,https://www.ncbi.nlm.nih.gov/pubmed/16887123|https://www.ncbi.nlm.nih.gov/pubmed/16979396|https://www.ncbi.nlm.nih.gov/pubmed/17996241|https://www.ncbi.nlm.nih.gov/pubmed/18249215|https://www.ncbi.nlm.nih.gov/pubmed/19131065,16887123|16979396|17996241|18249215|19131065,,
32,63110,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,9370,ADIPOQ,https://ctdbase.org/detail.go?type=gene&acc=9370,,,9370.0,ADIPOQ,10090.0,Mus musculus (house mouse),HCAR2 protein promotes the reaction [niacin results in increased expression of ADIPOQ protein]|niacin results in increased expression of ADIPOQ protein,,,PMID:19141678,https://www.ncbi.nlm.nih.gov/pubmed/19141678,19141678,,
33,63111,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,9370,ADIPOQ,https://ctdbase.org/detail.go?type=gene&acc=9370,,,9370.0,ADIPOQ,10090.0,Mus musculus (house mouse),Niacin results in increased expression of ADIPOQ mRNA,,,PMID:21236357,https://www.ncbi.nlm.nih.gov/pubmed/21236357,21236357,,
34,63112,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,9370,ADIPOQ,https://ctdbase.org/detail.go?type=gene&acc=9370,,,9370.0,ADIPOQ,9986.0,Oryctolagus cuniculus (rabbit),Niacin inhibits the reaction [cholesterol results in decreased expression of ADIPOQ protein],,,PMID:17611329,https://www.ncbi.nlm.nih.gov/pubmed/17611329,17611329,,
35,63113,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,135,ADORA2A,https://ctdbase.org/detail.go?type=gene&acc=135,,,135.0,ADORA2A,10090.0,Mus musculus (house mouse),[curcumin co-treated with niacin co-treated with ZM 241385] inhibits the reaction [rotenone results in increased expression of ADORA2A mrna]|niacin inhibits the reaction [rotenone results in increased expression of ADORA2A mrna],,,PMID:31820278,https://www.ncbi.nlm.nih.gov/pubmed/31820278,31820278,,
36,63114,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,183,AGT,https://ctdbase.org/detail.go?type=gene&acc=183,,,183.0,AGT,9606.0,Homo sapiens (human),Niacin inhibits the reaction [AGT protein results in increased abundance of reactive oxygen species],,,PMID:18550065,https://www.ncbi.nlm.nih.gov/pubmed/18550065,18550065,,
37,63115,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,183,AGT,https://ctdbase.org/detail.go?type=gene&acc=183,,,183.0,AGT,10090.0,Mus musculus (house mouse),Niacin inhibits the reaction [rotenone results in increased expression of AGT protein]|[curcumin co-treated with niacin co-treated with ZM 241385] inhibits the reaction [rotenone results in increased expression of AGT protein],,,PMID:31820278,https://www.ncbi.nlm.nih.gov/pubmed/31820278,31820278,,
38,63116,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,183,AGT,https://ctdbase.org/detail.go?type=gene&acc=183,,,183.0,AGT,10116.0,Rattus norvegicus (Norway rat),Niacin results in decreased expression of AGT protein,,,PMID:18374418,https://www.ncbi.nlm.nih.gov/pubmed/18374418,18374418,,
39,63269,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,197,AHSG,https://ctdbase.org/detail.go?type=gene&acc=197,,,197.0,AHSG,9606.0,Homo sapiens (human),Niacin results in decreased expression of and results in decreased phosphorylation of AHSG protein,,,PMID:19405044,https://www.ncbi.nlm.nih.gov/pubmed/19405044,19405044,,
40,63270,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10116.0,Rattus norvegicus (Norway rat),[niacin co-treated with chromium] results in increased phosphorylation of AKT1 protein,,,PMID:19027847,https://www.ncbi.nlm.nih.gov/pubmed/19027847,19027847,,
41,63271,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,284,ANGPT1,https://ctdbase.org/detail.go?type=gene&acc=284,,,284.0,ANGPT1,10090.0,Mus musculus (house mouse),Niacin results in increased expression of ANGPT1 mRNA,,,PMID:17557352,https://www.ncbi.nlm.nih.gov/pubmed/17557352,17557352,,
42,63272,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,285,ANGPT2,https://ctdbase.org/detail.go?type=gene&acc=285,,,285.0,ANGPT2,10090.0,Mus musculus (house mouse),Niacin results in decreased expression of ANGPT2 mRNA,,,PMID:17557352,https://www.ncbi.nlm.nih.gov/pubmed/17557352,17557352,,
43,63273,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,335,APOA1,https://ctdbase.org/detail.go?type=gene&acc=335,,,335.0,APOA1,9606.0,Homo sapiens (human),[chromium co-treated with niacin] results in increased expression of APOA1 mRNA,,,PMID:18602814,https://www.ncbi.nlm.nih.gov/pubmed/18602814,18602814,,
44,63274,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,335,APOA1,https://ctdbase.org/detail.go?type=gene&acc=335,,,335.0,APOA1,9606.0,Homo sapiens (human),[lovastatin co-treated with niacin] results in increased expression of APOA1 protein,,,PMID:17319473,https://www.ncbi.nlm.nih.gov/pubmed/17319473,17319473,,
45,63275,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,335,APOA1,https://ctdbase.org/detail.go?type=gene&acc=335,,,335.0,APOA1,9606.0,Homo sapiens (human),[niacin co-treated with ezetimibe co-treated with simvastatin] results in increased expression of APOA1 protein,,,PMID:20152243,https://www.ncbi.nlm.nih.gov/pubmed/20152243,20152243,,
46,63276,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,335,APOA1,https://ctdbase.org/detail.go?type=gene&acc=335,,,335.0,APOA1,9606.0,Homo sapiens (human),[niacin co-treated with lovastatin] results in increased expression of APOA1 protein,,,PMID:12633795,https://www.ncbi.nlm.nih.gov/pubmed/12633795,12633795,,
47,63277,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,335,APOA1,https://ctdbase.org/detail.go?type=gene&acc=335,,,335.0,APOA1,9606.0,Homo sapiens (human),Niacin promotes the reaction [rosuvastatin calcium results in increased expression of APOA1 protein],,,PMID:12767421|PMID:15539964,https://www.ncbi.nlm.nih.gov/pubmed/12767421|https://www.ncbi.nlm.nih.gov/pubmed/15539964,12767421|15539964,,
48,63278,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,335,APOA1,https://ctdbase.org/detail.go?type=gene&acc=335,,,335.0,APOA1,9606.0,Homo sapiens (human),Niacin promotes the reaction [[simvastatin co-treated with ezetimibe] results in increased expression of APOA1 protein],,,PMID:18420099,https://www.ncbi.nlm.nih.gov/pubmed/18420099,18420099,,
49,63279,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,335,APOA1,https://ctdbase.org/detail.go?type=gene&acc=335,,,335.0,APOA1,9606.0,Homo sapiens (human),Niacin results in increased expression of APOA1 protein,,,PMID:11701466|PMID:12767421|PMID:15539964|PMID:18566298,https://www.ncbi.nlm.nih.gov/pubmed/11701466|https://www.ncbi.nlm.nih.gov/pubmed/12767421|https://www.ncbi.nlm.nih.gov/pubmed/15539964|https://www.ncbi.nlm.nih.gov/pubmed/18566298,11701466|12767421|15539964|18566298,,
50,63464,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,335,APOA1,https://ctdbase.org/detail.go?type=gene&acc=335,,,335.0,APOA1,10090.0,Mus musculus (house mouse),2-chloro-5-nitrobenzanilide inhibits the reaction [niacin promotes the reaction [APOA1 protein results in increased export of cholesterol]]|pparg protein promotes the reaction [niacin promotes the reaction [APOA1 protein results in increased export of cholesterol]]|niacin promotes the reaction [APOA1 protein results in increased export of cholesterol],,,PMID:19797938,https://www.ncbi.nlm.nih.gov/pubmed/19797938,19797938,,
51,63465,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,338,APOB,https://ctdbase.org/detail.go?type=gene&acc=338,,,338.0,APOB,9606.0,Homo sapiens (human),[niacin co-treated with lovastatin] results in decreased expression of APOB protein,,,PMID:12633795,https://www.ncbi.nlm.nih.gov/pubmed/12633795,12633795,,
52,63466,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,338,APOB,https://ctdbase.org/detail.go?type=gene&acc=338,,,338.0,APOB,9606.0,Homo sapiens (human),[niacin co-treated with simvastatin] results in decreased expression of APOB protein,,,PMID:18471454,https://www.ncbi.nlm.nih.gov/pubmed/18471454,18471454,,
53,63467,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,338,APOB,https://ctdbase.org/detail.go?type=gene&acc=338,,,338.0,APOB,9606.0,Homo sapiens (human),Niacin results in decreased expression of APOB protein,,,PMID:11701466|PMID:15539964,https://www.ncbi.nlm.nih.gov/pubmed/11701466|https://www.ncbi.nlm.nih.gov/pubmed/15539964,11701466|15539964,,
54,63468,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,23779,ARHGAP8,https://ctdbase.org/detail.go?type=gene&acc=23779,,,23779.0,ARHGAP8,10116.0,Rattus norvegicus (Norway rat),Niacin results in increased expression of ARHGAP8 mRNA,,,PMID:20303128,https://www.ncbi.nlm.nih.gov/pubmed/20303128,20303128,,
55,63469,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,444,ASPH,https://ctdbase.org/detail.go?type=gene&acc=444,,,444.0,ASPH,10090.0,Mus musculus (house mouse),LEPR gene mutant form promotes the reaction [[niacin binds to chromium] which results in increased expression of ASPH mrna],,,PMID:16940432,https://www.ncbi.nlm.nih.gov/pubmed/16940432,16940432,,
56,63470,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,506,ATP5F1B,https://ctdbase.org/detail.go?type=gene&acc=506,,,506.0,ATP5F1B,9606.0,Homo sapiens (human),Niacin results in decreased expression of ATP5F1B protein,,,PMID:18316796,https://www.ncbi.nlm.nih.gov/pubmed/18316796,18316796,,
57,63471,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,627,BDNF,https://ctdbase.org/detail.go?type=gene&acc=627,,,627.0,BDNF,10116.0,Rattus norvegicus (Norway rat),Niacin results in increased expression of BDNF protein,,,PMID:20671245,https://www.ncbi.nlm.nih.gov/pubmed/20671245,20671245,,
58,63472,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,685,BTC,https://ctdbase.org/detail.go?type=gene&acc=685,,,685.0,BTC,10090.0,Mus musculus (house mouse),LEPR gene mutant form promotes the reaction [[niacin binds to chromium] which results in decreased expression of BTC mrna],,,PMID:16940432,https://www.ncbi.nlm.nih.gov/pubmed/16940432,16940432,,
59,63473,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10090.0,Mus musculus (house mouse),Niacin inhibits the reaction [rotenone results in increased activity of CASP3 protein]|[curcumin co-treated with niacin co-treated with ZM 241385] inhibits the reaction [rotenone results in increased activity of CASP3 protein],,,PMID:31820278,https://www.ncbi.nlm.nih.gov/pubmed/31820278,31820278,,
60,63635,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,844,CASQ1,https://ctdbase.org/detail.go?type=gene&acc=844,,,844.0,CASQ1,10090.0,Mus musculus (house mouse),LEPR gene mutant form promotes the reaction [[niacin binds to chromium] which results in increased expression of CASQ1 mrna],,,PMID:16940432,https://www.ncbi.nlm.nih.gov/pubmed/16940432,16940432,,
61,63636,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116.0,Rattus norvegicus (Norway rat),[niacin co-treated with chromium] results in increased activity of CAT protein,,,PMID:16931439,https://www.ncbi.nlm.nih.gov/pubmed/16931439,16931439,,
62,63637,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116.0,Rattus norvegicus (Norway rat),Niacin results in increased expression of CAT protein,,,PMID:19420110,https://www.ncbi.nlm.nih.gov/pubmed/19420110,19420110,,
63,63638,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,857,CAV1,https://ctdbase.org/detail.go?type=gene&acc=857,,,857.0,CAV1,10116.0,Rattus norvegicus (Norway rat),[niacin co-treated with chromium] inhibits the reaction [CAV1 protein binds to NOS3 protein]|[niacin co-treated with chromium] results in decreased expression of CAV1 protein,,,PMID:19027847,https://www.ncbi.nlm.nih.gov/pubmed/19027847,19027847,,
64,63639,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,859,CAV3,https://ctdbase.org/detail.go?type=gene&acc=859,,,859.0,CAV3,10116.0,Rattus norvegicus (Norway rat),[niacin co-treated with chromium] promotes the reaction [SLC2A4 protein binds to CAV3 protein]|[niacin co-treated with chromium] results in increased expression of CAV3 protein,,,PMID:19027847,https://www.ncbi.nlm.nih.gov/pubmed/19027847,19027847,,
65,63640,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,9606.0,Homo sapiens (human),Niacin inhibits the reaction [TNF protein results in increased expression of CCL2 protein]|niacin results in decreased expression of CCL2 protein,,,PMID:18550065,https://www.ncbi.nlm.nih.gov/pubmed/18550065,18550065,,
66,63641,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,9986.0,Oryctolagus cuniculus (rabbit),Niacin results in decreased expression of CCL2 mrna|niacin inhibits the reaction [TNF protein results in increased expression of CCL2 mrna],,,PMID:20167660,https://www.ncbi.nlm.nih.gov/pubmed/20167660,20167660,,
67,63642,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,10116.0,Rattus norvegicus (Norway rat),Niacin results in decreased expression of CCL2 protein,,,PMID:19420110,https://www.ncbi.nlm.nih.gov/pubmed/19420110,19420110,,
68,63643,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,948,CD36,https://ctdbase.org/detail.go?type=gene&acc=948,,,948.0,CD36,9606.0,Homo sapiens (human),Niacin results in increased expression of CD36 mRNA,,,PMID:24767308,https://www.ncbi.nlm.nih.gov/pubmed/24767308,24767308,,
69,63644,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,948,CD36,https://ctdbase.org/detail.go?type=gene&acc=948,,,948.0,CD36,9986.0,Oryctolagus cuniculus (rabbit),Niacin inhibits the reaction [cholesterol results in decreased expression of CD36 mrna],,,PMID:18402819,https://www.ncbi.nlm.nih.gov/pubmed/18402819,18402819,,
70,63798,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,948,CD36,https://ctdbase.org/detail.go?type=gene&acc=948,,,948.0,CD36,10116.0,Rattus norvegicus (Norway rat),Niacin results in decreased expression of CD36 protein,,,PMID:19878707,https://www.ncbi.nlm.nih.gov/pubmed/19878707,19878707,,
71,63799,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,10116.0,Rattus norvegicus (Norway rat),Etoposide promotes the reaction [niacin deficiency results in increased expression of CDKN1A protein]|niacin deficiency results in increased expression of CDKN1A protein,,,PMID:17516866,https://www.ncbi.nlm.nih.gov/pubmed/17516866,17516866,,
72,63800,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,1050,CEBPA,https://ctdbase.org/detail.go?type=gene&acc=1050,,,1050.0,CEBPA,9606.0,Homo sapiens (human),Niacin results in increased expression of CEBPA mRNA,,,PMID:19131065,https://www.ncbi.nlm.nih.gov/pubmed/19131065,19131065,,
73,63801,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,1051,CEBPB,https://ctdbase.org/detail.go?type=gene&acc=1051,,,1051.0,CEBPB,10090.0,Mus musculus (house mouse),Niacin inhibits the reaction [CEBPB protein binds to PTGS2 promoter]|niacin results in decreased expression of CEBPB protein|niacin results in decreased expression of CEBPB mrna|[niacin inhibits the reaction [CEBPB protein binds to PTGS2 promoter]] which results in decreased expression of PTGS2 mRNA,,,PMID:21236357,https://www.ncbi.nlm.nih.gov/pubmed/21236357,21236357,,
74,63802,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,1052,CEBPD,https://ctdbase.org/detail.go?type=gene&acc=1052,,,1052.0,CEBPD,9606.0,Homo sapiens (human),Niacin results in increased expression of CEBPD mRNA,,,PMID:19131065,https://www.ncbi.nlm.nih.gov/pubmed/19131065,19131065,,
75,63803,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,10087,CERT1,https://ctdbase.org/detail.go?type=gene&acc=10087,,,10087.0,CERT1,10090.0,Mus musculus (house mouse),"Niacin results in decreased expression of and results in decreased activity of CERT1 protein|[niacin results in decreased expression of and results in decreased activity of CERT1 protein] which results in increased abundance of cholesterol, HDL",,,PMID:18669886,https://www.ncbi.nlm.nih.gov/pubmed/18669886,18669886,,
76,63804,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,1124,CHN2,https://ctdbase.org/detail.go?type=gene&acc=1124,,,1124.0,CHN2,10116.0,Rattus norvegicus (Norway rat),Niacin results in increased expression of CHN2 mRNA,,,PMID:20303128,https://www.ncbi.nlm.nih.gov/pubmed/20303128,20303128,,
77,63805,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,1149,CIDEA,https://ctdbase.org/detail.go?type=gene&acc=1149,,,1149.0,CIDEA,10090.0,Mus musculus (house mouse),LEPR gene mutant form promotes the reaction [[niacin binds to chromium] which results in decreased expression of CIDEA mrna],,,PMID:16940432,https://www.ncbi.nlm.nih.gov/pubmed/16940432,16940432,,
78,63806,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,1376,CPT2,https://ctdbase.org/detail.go?type=gene&acc=1376,,,1376.0,CPT2,9606.0,Homo sapiens (human),Niacin results in decreased expression of CPT2 mRNA,,,PMID:19131065,https://www.ncbi.nlm.nih.gov/pubmed/19131065,19131065,,
79,63807,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,1401,CRP,https://ctdbase.org/detail.go?type=gene&acc=1401,,,1401.0,CRP,9606.0,Homo sapiens (human),Niacin results in decreased expression of CRP protein,,,PMID:16950175|PMID:18420099,https://www.ncbi.nlm.nih.gov/pubmed/16950175|https://www.ncbi.nlm.nih.gov/pubmed/18420099,16950175|18420099,,
80,63951,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,1401,CRP,https://ctdbase.org/detail.go?type=gene&acc=1401,,,1401.0,CRP,9606.0,Homo sapiens (human),"[resveratrol co-treated with pterostilbene co-treated with quercetin co-treated with tocotrienol, delta co-treated with niacin] results in decreased expression of CRP protein",,,PMID:24319627,https://www.ncbi.nlm.nih.gov/pubmed/24319627,24319627,,
81,63952,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,1401,CRP,https://ctdbase.org/detail.go?type=gene&acc=1401,,,1401.0,CRP,9606.0,Homo sapiens (human),[simvastatin co-treated with ezetimibe] promotes the reaction [niacin results in decreased expression of CRP protein],,,PMID:18420099,https://www.ncbi.nlm.nih.gov/pubmed/18420099,18420099,,
82,63953,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,1401,CRP,https://ctdbase.org/detail.go?type=gene&acc=1401,,,1401.0,CRP,10090.0,Mus musculus (house mouse),Niacin inhibits the reaction [rotenone results in increased expression of CRP protein]|[curcumin co-treated with niacin co-treated with ZM 241385] inhibits the reaction [rotenone results in increased expression of CRP protein],,,PMID:31820278,https://www.ncbi.nlm.nih.gov/pubmed/31820278,31820278,,
83,63954,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,140880,CST11,https://ctdbase.org/detail.go?type=gene&acc=140880,,,140880.0,CST11,10116.0,Rattus norvegicus (Norway rat),Niacin results in increased expression of CST11 mRNA,,,PMID:20303128,https://www.ncbi.nlm.nih.gov/pubmed/20303128,20303128,,
84,63955,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,10047,CST8,https://ctdbase.org/detail.go?type=gene&acc=10047,,,10047.0,CST8,10116.0,Rattus norvegicus (Norway rat),Niacin results in increased expression of CST8 mRNA,,,PMID:20303128,https://www.ncbi.nlm.nih.gov/pubmed/20303128,20303128,,
85,63956,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),[ubiquinone co-treated with niacin co-treated with riboflavin] promotes the reaction [tamoxifen results in decreased expression of CXCL8 protein],,,PMID:17516992,https://www.ncbi.nlm.nih.gov/pubmed/17516992,17516992,,
86,63957,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,1535,CYBA,https://ctdbase.org/detail.go?type=gene&acc=1535,,,1535.0,CYBA,10116.0,Rattus norvegicus (Norway rat),Niacin results in decreased expression of CYBA protein,,,PMID:19420110,https://www.ncbi.nlm.nih.gov/pubmed/19420110,19420110,,
87,63958,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,80821,DDHD1,https://ctdbase.org/detail.go?type=gene&acc=80821,,,80821.0,DDHD1,10090.0,Mus musculus (house mouse),LEPR gene mutant form promotes the reaction [[niacin binds to chromium] which results in decreased expression of DDHD1 mrna],,,PMID:16940432,https://www.ncbi.nlm.nih.gov/pubmed/16940432,16940432,,
88,63959,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,84649,DGAT2,https://ctdbase.org/detail.go?type=gene&acc=84649,,,84649.0,DGAT2,9606.0,Homo sapiens (human),[niacin results in decreased activity of DGAT2 protein] which results in decreased chemical synthesis of triglycerides|niacin results in decreased activity of DGAT2 protein,,,PMID:15258194,https://www.ncbi.nlm.nih.gov/pubmed/15258194,15258194,,
89,63960,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,1847,DUSP5,https://ctdbase.org/detail.go?type=gene&acc=1847,,,1847.0,DUSP5,10116.0,Rattus norvegicus (Norway rat),Niacin results in increased expression of DUSP5 mRNA,,,PMID:20303128,https://www.ncbi.nlm.nih.gov/pubmed/20303128,20303128,,
90,64146,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,9427,ECEL1,https://ctdbase.org/detail.go?type=gene&acc=9427,,,9427.0,ECEL1,10116.0,Rattus norvegicus (Norway rat),Niacin results in increased expression of ECEL1 mRNA,,,PMID:20303128,https://www.ncbi.nlm.nih.gov/pubmed/20303128,20303128,,
91,64147,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,1910,EDNRB,https://ctdbase.org/detail.go?type=gene&acc=1910,,,1910.0,EDNRB,10090.0,Mus musculus (house mouse),LEPR gene mutant form promotes the reaction [[niacin binds to chromium] which results in increased expression of EDNRB mrna],,,PMID:16940432,https://www.ncbi.nlm.nih.gov/pubmed/16940432,16940432,,
92,64148,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,1959,EGR2,https://ctdbase.org/detail.go?type=gene&acc=1959,,,1959.0,EGR2,10116.0,Rattus norvegicus (Norway rat),Niacin results in increased expression of EGR2 mRNA,,,PMID:20303128,https://www.ncbi.nlm.nih.gov/pubmed/20303128,20303128,,
93,64149,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,83939,EIF2A,https://ctdbase.org/detail.go?type=gene&acc=83939,,,83939.0,EIF2A,10116.0,Rattus norvegicus (Norway rat),Niacin results in increased phosphorylation of EIF2A protein,,,PMID:12837665,https://www.ncbi.nlm.nih.gov/pubmed/12837665,12837665,,
94,64150,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,1978,EIF4EBP1,https://ctdbase.org/detail.go?type=gene&acc=1978,,,1978.0,EIF4EBP1,10116.0,Rattus norvegicus (Norway rat),Niacin results in decreased phosphorylation of and results in decreased activity of EIF4EBP1 protein,,,PMID:12837665,https://www.ncbi.nlm.nih.gov/pubmed/12837665,12837665,,
95,64151,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,2027,ENO3,https://ctdbase.org/detail.go?type=gene&acc=2027,,,2027.0,ENO3,10090.0,Mus musculus (house mouse),LEPR gene mutant form promotes the reaction [[niacin binds to chromium] which results in increased expression of ENO3 mrna],,,PMID:16940432,https://www.ncbi.nlm.nih.gov/pubmed/16940432,16940432,,
96,64152,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,2149,F2R,https://ctdbase.org/detail.go?type=gene&acc=2149,,,2149.0,F2R,9606.0,Homo sapiens (human),Niacin results in increased expression of F2R protein,,,PMID:20539903,https://www.ncbi.nlm.nih.gov/pubmed/20539903,20539903,,
97,64153,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,2168,FABP1,https://ctdbase.org/detail.go?type=gene&acc=2168,,,2168.0,FABP1,10116.0,Rattus norvegicus (Norway rat),Niacin results in increased expression of FABP1 protein,,,PMID:19878707,https://www.ncbi.nlm.nih.gov/pubmed/19878707,19878707,,
98,64154,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,2167,FABP4,https://ctdbase.org/detail.go?type=gene&acc=2167,,,2167.0,FABP4,10090.0,Mus musculus (house mouse),Fluprostenol inhibits the reaction [niacin results in increased expression of FABP4 mrna]|[niacin results in decreased abundance of dinoprost] which results in increased expression of FABP4 mrna|[niacin results in decreased abundance of dinoprost] which results in increased expression of FABP4 protein,,,PMID:21236357,https://www.ncbi.nlm.nih.gov/pubmed/21236357,21236357,,
99,64155,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,2194,FASN,https://ctdbase.org/detail.go?type=gene&acc=2194,,,2194.0,FASN,9606.0,Homo sapiens (human),Niacin results in decreased expression of FASN mRNA,,,PMID:19131065,https://www.ncbi.nlm.nih.gov/pubmed/19131065,19131065,,
100,64344,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,2308,FOXO1,https://ctdbase.org/detail.go?type=gene&acc=2308,,,2308.0,FOXO1,10116.0,Rattus norvegicus (Norway rat),Niacin results in decreased phosphorylation of and results in increased activity of FOXO1 protein,,,PMID:20303128,https://www.ncbi.nlm.nih.gov/pubmed/20303128,20303128,,
101,64345,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,181646,GAS-1,https://ctdbase.org/detail.go?type=gene&acc=181646,,,181646.0,gas-1,6239.0,Caenorhabditis elegans,Niacin inhibits the reaction [GAS-1 gene mutant form results in decreased abundance of NAD],,,PMID:25744875,https://www.ncbi.nlm.nih.gov/pubmed/25744875,25744875,,
102,64346,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,2641,GCG,https://ctdbase.org/detail.go?type=gene&acc=2641,,,2641.0,GCG,9606.0,Homo sapiens (human),"Glucose inhibits the reaction [[niacin results in decreased abundance of fatty acids, nonesterified] which results in increased secretion of GCG protein]|[niacin results in decreased abundance of fatty acids, nonesterified] which results in increased secretion of GCG protein",,,PMID:838844,https://www.ncbi.nlm.nih.gov/pubmed/838844,838844,,
103,64347,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,2678,GGT1,https://ctdbase.org/detail.go?type=gene&acc=2678,,,2678.0,GGT1,10116.0,Rattus norvegicus (Norway rat),Niacin results in increased expression of GGT1 mRNA,,,PMID:20303128,https://www.ncbi.nlm.nih.gov/pubmed/20303128,20303128,,
104,64348,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,2688,GH1,https://ctdbase.org/detail.go?type=gene&acc=2688,,,2688.0,GH1,9606.0,Homo sapiens (human),"Glucose inhibits the reaction [[niacin results in decreased abundance of fatty acids, nonesterified] which results in increased secretion of GH1 protein]|[niacin results in decreased abundance of fatty acids, nonesterified] which results in increased secretion of GH1 protein",,,PMID:838844,https://www.ncbi.nlm.nih.gov/pubmed/838844,838844,,
105,64349,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,2688,GH1,https://ctdbase.org/detail.go?type=gene&acc=2688,,,2688.0,GH1,9544.0,Macaca mulatta (Rhesus monkey),"[niacin results in decreased abundance of fatty acids, nonesterified] which results in increased secretion of GH1 protein|oleic acid inhibits the reaction [[niacin results in decreased abundance of fatty acids, nonesterified] which results in increased secretion of GH1 protein]|3-hydroxybutyric acid inhibits the reaction [[niacin results in decreased abundance of fatty acids, nonesterified] which results in increased secretion of GH1 protein]",,,PMID:1890151,https://www.ncbi.nlm.nih.gov/pubmed/1890151,1890151,,
106,64350,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,2805,GOT1,https://ctdbase.org/detail.go?type=gene&acc=2805,,,2805.0,GOT1,10090.0,Mus musculus (house mouse),Niacin inhibits the reaction [dietary fats results in increased activity of GOT1 protein],,,PMID:24484068,https://www.ncbi.nlm.nih.gov/pubmed/24484068,24484068,,
107,64351,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,2819,GPD1,https://ctdbase.org/detail.go?type=gene&acc=2819,,,2819.0,GPD1,10090.0,Mus musculus (house mouse),[INS1 protein co-treated with niacin] results in increased activity of GPD1 protein,,,PMID:2523799,https://www.ncbi.nlm.nih.gov/pubmed/2523799,2523799,,
108,64352,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,14751,GPI1,https://ctdbase.org/detail.go?type=gene&acc=14751,,,14751.0,Gpi1,10090.0,Mus musculus (house mouse),LEPR gene mutant form promotes the reaction [[niacin binds to chromium] which results in increased expression of GPI1 mrna],,,PMID:16940432,https://www.ncbi.nlm.nih.gov/pubmed/16940432,16940432,,
109,64353,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10090.0,Mus musculus (house mouse),Niacin inhibits the reaction [dietary fats results in increased activity of GPT protein],,,PMID:24484068,https://www.ncbi.nlm.nih.gov/pubmed/24484068,24484068,,
110,64497,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,338442,HCAR2,https://ctdbase.org/detail.go?type=gene&acc=338442,,,338442.0,HCAR2,9606.0,Homo sapiens (human),HCAR2 protein promotes the reaction [niacin results in increased expression of and results in increased activity of PPARG protein],,,PMID:16386710,https://www.ncbi.nlm.nih.gov/pubmed/16386710,16386710,,
111,64498,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,338442,HCAR2,https://ctdbase.org/detail.go?type=gene&acc=338442,,,338442.0,HCAR2,9606.0,Homo sapiens (human),Niacin binds to and affects the activity of HCAR2 protein,,,PMID:16018973,https://www.ncbi.nlm.nih.gov/pubmed/16018973,16018973,,
112,64499,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,338442,HCAR2,https://ctdbase.org/detail.go?type=gene&acc=338442,,,338442.0,HCAR2,9606.0,Homo sapiens (human),Niacin binds to and results in increased activity of HCAR2 protein,,,PMID:16389067|PMID:20380810|PMID:20452209|PMID:20460384|PMID:21167710,https://www.ncbi.nlm.nih.gov/pubmed/16389067|https://www.ncbi.nlm.nih.gov/pubmed/20380810|https://www.ncbi.nlm.nih.gov/pubmed/20452209|https://www.ncbi.nlm.nih.gov/pubmed/20460384|https://www.ncbi.nlm.nih.gov/pubmed/21167710,16389067|20380810|20452209|20460384|21167710,,
113,64500,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,338442,HCAR2,https://ctdbase.org/detail.go?type=gene&acc=338442,,,338442.0,HCAR2,9606.0,Homo sapiens (human),[niacin binds to and results in increased activity of HCAR2 protein] which results in increased phosphorylation of MAPK3 protein|[niacin binds to and results in increased activity of HCAR2 protein] which results in increased phosphorylation of MAPK1 protein,,,PMID:16389067,https://www.ncbi.nlm.nih.gov/pubmed/16389067,16389067,,
114,64501,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,338442,HCAR2,https://ctdbase.org/detail.go?type=gene&acc=338442,,,338442.0,HCAR2,9606.0,Homo sapiens (human),Niacin binds to HCAR2 protein,,,PMID:16099840,https://www.ncbi.nlm.nih.gov/pubmed/16099840,16099840,,
115,64502,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,338442,HCAR2,https://ctdbase.org/detail.go?type=gene&acc=338442,,,338442.0,HCAR2,9606.0,Homo sapiens (human),Niacin results in increased activity of HCAR2 protein,,,PMID:15929991|PMID:19223991,https://www.ncbi.nlm.nih.gov/pubmed/15929991|https://www.ncbi.nlm.nih.gov/pubmed/19223991,15929991|19223991,,
116,64503,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,338442,HCAR2,https://ctdbase.org/detail.go?type=gene&acc=338442,,,338442.0,HCAR2,9606.0,Homo sapiens (human),[niacin results in increased activity of HCAR2 protein] inhibits the reaction [colforsin results in increased abundance of cyclic AMP],,,PMID:19223991,https://www.ncbi.nlm.nih.gov/pubmed/19223991,19223991,,
117,64504,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,338442,HCAR2,https://ctdbase.org/detail.go?type=gene&acc=338442,,,338442.0,HCAR2,10090.0,Mus musculus (house mouse),HCAR2 protein inhibits the reaction [[niacin results in increased expression of ABCG1 protein] which results in increased export of cholesterol],,,PMID:21317532,https://www.ncbi.nlm.nih.gov/pubmed/21317532,21317532,,
118,64505,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,338442,HCAR2,https://ctdbase.org/detail.go?type=gene&acc=338442,,,338442.0,HCAR2,10090.0,Mus musculus (house mouse),HCAR2 protein promotes the reaction [niacin results in increased expression of ADIPOQ protein]|hcar2 protein promotes the reaction [niacin results in decreased abundance of fatty acids],,,PMID:19141678,https://www.ncbi.nlm.nih.gov/pubmed/19141678,19141678,,
119,64506,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,338442,HCAR2,https://ctdbase.org/detail.go?type=gene&acc=338442,,,338442.0,HCAR2,10090.0,Mus musculus (house mouse),HCAR2 protein results in increased susceptibility to niacin|[hcar2 protein results in increased susceptibility to niacin] which results in increased abundance of dinoprostone|[hcar2 protein results in increased susceptibility to niacin] which results in increased abundance of prostaglandin D2,,,PMID:16322797,https://www.ncbi.nlm.nih.gov/pubmed/16322797,16322797,,
120,64671,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,338442,HCAR2,https://ctdbase.org/detail.go?type=gene&acc=338442,,,338442.0,HCAR2,10090.0,Mus musculus (house mouse),Niacin affects the activity of HCAR2 protein,,,PMID:15929991|PMID:18722346,https://www.ncbi.nlm.nih.gov/pubmed/15929991|https://www.ncbi.nlm.nih.gov/pubmed/18722346,15929991|18722346,,
121,64672,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,338442,HCAR2,https://ctdbase.org/detail.go?type=gene&acc=338442,,,338442.0,HCAR2,10090.0,Mus musculus (house mouse),Niacin binds to and results in increased activity of HCAR2 protein,,,PMID:12563315|PMID:20655299|PMID:21317532,https://www.ncbi.nlm.nih.gov/pubmed/12563315|https://www.ncbi.nlm.nih.gov/pubmed/20655299|https://www.ncbi.nlm.nih.gov/pubmed/21317532,12563315|20655299|21317532,,
122,64673,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,338442,HCAR2,https://ctdbase.org/detail.go?type=gene&acc=338442,,,338442.0,HCAR2,10090.0,Mus musculus (house mouse),"[niacin binds to and results in increased activity of HCAR2 protein] which results in decreased abundance of fatty acids, nonesterified|[niacin binds to and results in increased activity of HCAR2 protein] which results in decreased abundance of triglycerides|[niacin binds to and results in increased activity of HCAR2 protein] which results in decreased abundance of cyclic AMP",,,PMID:12563315,https://www.ncbi.nlm.nih.gov/pubmed/12563315,12563315,,
123,64674,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,338442,HCAR2,https://ctdbase.org/detail.go?type=gene&acc=338442,,,338442.0,HCAR2,10090.0,Mus musculus (house mouse),[[niacin binds to and results in increased activity of HCAR2 protein] which results in decreased expression of ABCA1 protein] which results in decreased export of cholesterol|[niacin binds to and results in increased activity of HCAR2 protein] which results in decreased expression of ABCA1 protein,,,PMID:20655299,https://www.ncbi.nlm.nih.gov/pubmed/20655299,20655299,,
124,64675,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,338442,HCAR2,https://ctdbase.org/detail.go?type=gene&acc=338442,,,338442.0,HCAR2,10116.0,Rattus norvegicus (Norway rat),"[niacin analog binds to and results in increased activity of HCAR2 protein] which results in decreased abundance of fatty acids, nonesterified",,,PMID:19309152,https://www.ncbi.nlm.nih.gov/pubmed/19309152,19309152,,
125,64676,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,338442,HCAR2,https://ctdbase.org/detail.go?type=gene&acc=338442,,,338442.0,HCAR2,10116.0,Rattus norvegicus (Norway rat),Niacin binds to and results in increased activity of HCAR2 protein,,,PMID:17804224|PMID:19309152,https://www.ncbi.nlm.nih.gov/pubmed/17804224|https://www.ncbi.nlm.nih.gov/pubmed/19309152,17804224|19309152,,
126,64677,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,338442,HCAR2,https://ctdbase.org/detail.go?type=gene&acc=338442,,,338442.0,HCAR2,10116.0,Rattus norvegicus (Norway rat),"[niacin binds to and results in increased activity of HCAR2 protein] which results in decreased abundance of fatty acids, nonesterified",,,PMID:17804224,https://www.ncbi.nlm.nih.gov/pubmed/17804224,17804224,,
127,64678,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,338442,HCAR2,https://ctdbase.org/detail.go?type=gene&acc=338442,,,338442.0,HCAR2,9606.0,Homo sapiens (human),Niacin results in increased activity of HCAR2,,,PMID:24767308,https://www.ncbi.nlm.nih.gov/pubmed/24767308,24767308,,
128,64679,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,338442,HCAR2,https://ctdbase.org/detail.go?type=gene&acc=338442,,,338442.0,HCAR2,9606.0,Homo sapiens (human),[[niacin results in increased activity of HCAR2 protein] which results in increased chemical synthesis of prostaglandin D2] which results in increased chemical synthesis of 15-deoxyprostaglandin j2|[niacin results in increased activity of HCAR2 protein] which results in increased chemical synthesis of dinoprostone|[niacin results in increased activity of HCAR2 protein] which results in increased chemical synthesis of prostaglandin d2|niacin results in increased activity of HCAR2 protein,,,PMID:17430113,https://www.ncbi.nlm.nih.gov/pubmed/17430113,17430113,,
129,64866,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,8843,HCAR3,https://ctdbase.org/detail.go?type=gene&acc=8843,,,8843.0,HCAR3,9606.0,Homo sapiens (human),HCAR3 protein promotes the reaction [niacin results in increased activity of PPARG protein],,,PMID:16386710,https://www.ncbi.nlm.nih.gov/pubmed/16386710,16386710,,
130,64867,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,8843,HCAR3,https://ctdbase.org/detail.go?type=gene&acc=8843,,,8843.0,HCAR3,9606.0,Homo sapiens (human),[niacin binds to and results in increased activity of HCAR3 protein] which results in increased phosphorylation of MAPK3 protein|[niacin binds to and results in increased activity of HCAR3 protein] which results in increased phosphorylation of MAPK1 protein|niacin binds to and results in increased activity of HCAR3 protein,,,PMID:16389067,https://www.ncbi.nlm.nih.gov/pubmed/16389067,16389067,,
131,64868,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,8843,HCAR3,https://ctdbase.org/detail.go?type=gene&acc=8843,,,8843.0,HCAR3,9606.0,Homo sapiens (human),Niacin binds to HCAR3 protein,,,PMID:16480258,https://www.ncbi.nlm.nih.gov/pubmed/16480258,16480258,,
132,64869,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,8843,HCAR3,https://ctdbase.org/detail.go?type=gene&acc=8843,,,8843.0,HCAR3,9606.0,Homo sapiens (human),Niacin results in increased expression of HCAR3 mRNA,,,PMID:24767308,https://www.ncbi.nlm.nih.gov/pubmed/24767308,24767308,,
133,64870,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091.0,HIF1A,10116.0,Rattus norvegicus (Norway rat),Niacin results in decreased expression of HIF1A protein,,,PMID:18549825,https://www.ncbi.nlm.nih.gov/pubmed/18549825,18549825,,
134,64871,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10116.0,Rattus norvegicus (Norway rat),[[niacin binds to chromium] which co-treated with cardiotonic agents] results in increased expression of HMOX1 protein,,,PMID:16840737,https://www.ncbi.nlm.nih.gov/pubmed/16840737,16840737,,
135,64872,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,3315,HSPB1,https://ctdbase.org/detail.go?type=gene&acc=3315,,,3315.0,HSPB1,10116.0,Rattus norvegicus (Norway rat),[[niacin binds to chromium] which co-treated with cardiotonic agents] results in increased expression of HSPB1 protein,,,PMID:16840737,https://www.ncbi.nlm.nih.gov/pubmed/16840737,16840737,,
136,64873,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,9606.0,Homo sapiens (human),Niacin inhibits the reaction [IFNG protein results in increased expression of ICAM1 protein]|niacin results in decreased expression of ICAM1 protein|niacin inhibits the reaction [IL1B protein results in increased expression of ICAM1 protein],,,PMID:19159436,https://www.ncbi.nlm.nih.gov/pubmed/19159436,19159436,,
137,64874,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,9606.0,Homo sapiens (human),Niacin inhibits the reaction [TNF protein results in increased expression of ICAM1 mrna],,,PMID:16916501|PMID:19159436,https://www.ncbi.nlm.nih.gov/pubmed/16916501|https://www.ncbi.nlm.nih.gov/pubmed/19159436,16916501|19159436,,
138,64875,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,9986.0,Oryctolagus cuniculus (rabbit),Niacin inhibits the reaction [TNF protein results in increased expression of ICAM1 mrna]|niacin results in decreased expression of ICAM1 mRNA,,,PMID:20167660,https://www.ncbi.nlm.nih.gov/pubmed/20167660,20167660,,
139,65029,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,10116.0,Rattus norvegicus (Norway rat),[niacin co-treated with chromium] inhibits the reaction [dietary fats results in increased expression of ICAM1 protein]|[niacin co-treated with chromium] inhibits the reaction [dietary fats results in increased expression of ICAM1 mrna],,,PMID:18622720,https://www.ncbi.nlm.nih.gov/pubmed/18622720,18622720,,
140,65030,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,3458,IFNG,https://ctdbase.org/detail.go?type=gene&acc=3458,,,3458.0,IFNG,9606.0,Homo sapiens (human),Niacin inhibits the reaction [IFNG protein results in increased expression of ICAM1 protein],,,PMID:19159436,https://www.ncbi.nlm.nih.gov/pubmed/19159436,19159436,,
141,65031,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,9606.0,Homo sapiens (human),Niacin inhibits the reaction [IL1B protein results in increased expression of ICAM1 protein],,,PMID:19159436,https://www.ncbi.nlm.nih.gov/pubmed/19159436,19159436,,
142,65032,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,9606.0,Homo sapiens (human),[ubiquinone co-treated with niacin co-treated with riboflavin] promotes the reaction [tamoxifen results in decreased expression of IL1B protein],,,PMID:17516992,https://www.ncbi.nlm.nih.gov/pubmed/17516992,17516992,,
143,65033,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),[ubiquinone co-treated with niacin co-treated with riboflavin] promotes the reaction [tamoxifen results in decreased expression of IL6 protein],,,PMID:17516992,https://www.ncbi.nlm.nih.gov/pubmed/17516992,17516992,,
144,65034,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10090.0,Mus musculus (house mouse),[curcumin co-treated with niacin co-treated with ZM 241385] inhibits the reaction [rotenone results in increased expression of IL6 protein]|niacin inhibits the reaction [rotenone results in increased expression of IL6 protein],,,PMID:31820278,https://www.ncbi.nlm.nih.gov/pubmed/31820278,31820278,,
145,65035,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116.0,Rattus norvegicus (Norway rat),"Niacin inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of IL6 mrna]|niacin inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of IL6 protein]",,,PMID:20975550,https://www.ncbi.nlm.nih.gov/pubmed/20975550,20975550,,
146,65036,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333.0,Ins1,10090.0,Mus musculus (house mouse),[INS1 protein co-treated with niacin] results in increased activity of GPD1 protein,,,PMID:2523799,https://www.ncbi.nlm.nih.gov/pubmed/2523799,2523799,,
147,65037,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,3791,KDR,https://ctdbase.org/detail.go?type=gene&acc=3791,,,3791.0,KDR,10090.0,Mus musculus (house mouse),Niacin results in increased expression of KDR mRNA,,,PMID:17557352,https://www.ncbi.nlm.nih.gov/pubmed/17557352,17557352,,
148,65038,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,3845,KRAS,https://ctdbase.org/detail.go?type=gene&acc=3845,,,3845.0,KRAS,10090.0,Mus musculus (house mouse),Niacin affects the localization of KRAS protein,,,PMID:12106604,https://www.ncbi.nlm.nih.gov/pubmed/12106604,12106604,,
149,65199,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,13863,LCN5,https://ctdbase.org/detail.go?type=gene&acc=13863,,,13863.0,Lcn5,10116.0,Rattus norvegicus (Norway rat),Niacin results in increased expression of LCN5 mRNA,,,PMID:20303128,https://www.ncbi.nlm.nih.gov/pubmed/20303128,20303128,,
150,65200,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,3952,LEP,https://ctdbase.org/detail.go?type=gene&acc=3952,,,3952.0,LEP,9606.0,Homo sapiens (human),Niacin results in increased expression of LEP protein,,,PMID:16887123,https://www.ncbi.nlm.nih.gov/pubmed/16887123,16887123,,
151,65201,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,3952,LEP,https://ctdbase.org/detail.go?type=gene&acc=3952,,,3952.0,LEP,10090.0,Mus musculus (house mouse),Niacin results in increased expression of LEP mRNA,,,PMID:21236357,https://www.ncbi.nlm.nih.gov/pubmed/21236357,21236357,,
152,65202,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,3952,LEP,https://ctdbase.org/detail.go?type=gene&acc=3952,,,3952.0,LEP,9986.0,Oryctolagus cuniculus (rabbit),Niacin inhibits the reaction [cholesterol results in increased expression of LEP protein]|niacin inhibits the reaction [cholesterol results in increased expression of LEP mrna],,,PMID:18402819,https://www.ncbi.nlm.nih.gov/pubmed/18402819,18402819,,
153,65203,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,3953,LEPR,https://ctdbase.org/detail.go?type=gene&acc=3953,,,3953.0,LEPR,10090.0,Mus musculus (house mouse),LEPR gene mutant form promotes the reaction [[niacin binds to chromium] which results in increased expression of ASPH mrna]|lepr gene mutant form promotes the reaction [[niacin binds to chromium] which results in decreased expression of PCK1 mrna]|lepr gene mutant form promotes the reaction [[niacin binds to chromium] which results in decreased expression of DDHD1 mrna]|lepr gene mutant form promotes the reaction [[niacin binds to chromium] which results in increased expression of SRL mrna]|lepr gene mutant form promotes the reaction [[niacin binds to chromium] which results in increased expression of NRAP mrna]|lepr gene mutant form promotes the reaction [[niacin binds to chromium] which results in increased expression of RALGAPA1 mrna]|lepr gene mutant form promotes the reaction [[niacin binds to chromium] which results in decreased expression of CIDEA mrna]|lepr gene mutant form promotes the reaction [[niacin binds to chromium] which results in increased expression of PI16 mrna]|lepr gene mutant form promotes the reaction [[niacin binds to chromium] which results in decreased expression of UCP1 mrna]|lepr gene mutant form promotes the reaction [[niacin binds to chromium] which results in decreased expression of BTC mrna]|lepr gene mutant form promotes the reaction [[niacin binds to chromium] which results in increased expression of GPI1 mrna]|lepr gene mutant form promotes the reaction [[niacin binds to chromium] which results in increased expression of TLN1 mrna]|lepr gene mutant form promotes the reaction [[niacin binds to chromium] which results in increased expression of EDNRB mrna]|lepr gene mutant form promotes the reaction [[niacin binds to chromium] which results in increased expression of ENO3 mrna]|lepr gene mutant form promotes the reaction [[niacin binds to chromium] which results in decreased expression of NET1 mrna]|lepr gene mutant form promotes the reaction [[niacin binds to chromium] which results in increased expression of TPM1 mrna]|lepr gene mutant form promotes the reaction [[niacin binds to chromium] which results in increased expression of CASQ1 mrna]|lepr gene mutant form promotes the reaction [[niacin binds to chromium] which results in decreased expression of TTPA mrna],,,PMID:16940432,https://www.ncbi.nlm.nih.gov/pubmed/16940432,16940432,,
154,65204,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,3991,LIPE,https://ctdbase.org/detail.go?type=gene&acc=3991,,,3991.0,LIPE,9606.0,Homo sapiens (human),Niacin results in decreased activity of LIPE protein,,,PMID:14749208,https://www.ncbi.nlm.nih.gov/pubmed/14749208,14749208,,
155,65205,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,3991,LIPE,https://ctdbase.org/detail.go?type=gene&acc=3991,,,3991.0,LIPE,9606.0,Homo sapiens (human),Niacin results in decreased expression of LIPE mRNA,,,PMID:19131065,https://www.ncbi.nlm.nih.gov/pubmed/19131065,19131065,,
156,65206,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,9516,LITAF,https://ctdbase.org/detail.go?type=gene&acc=9516,,,9516.0,LITAF,10116.0,Rattus norvegicus (Norway rat),Niacin results in increased expression of LITAF mRNA,,,PMID:20303128,https://www.ncbi.nlm.nih.gov/pubmed/20303128,20303128,,
157,65373,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,4018,LPA,https://ctdbase.org/detail.go?type=gene&acc=4018,,,4018.0,LPA,9606.0,Homo sapiens (human),[lovastatin co-treated with niacin] results in decreased expression of LPA protein,,,PMID:17319473,https://www.ncbi.nlm.nih.gov/pubmed/17319473,17319473,,
158,65374,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,4018,LPA,https://ctdbase.org/detail.go?type=gene&acc=4018,,,4018.0,LPA,9606.0,Homo sapiens (human),[niacin co-treated with lovastatin] results in decreased expression of LPA protein,,,PMID:12633795,https://www.ncbi.nlm.nih.gov/pubmed/12633795,12633795,,
159,65375,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,4018,LPA,https://ctdbase.org/detail.go?type=gene&acc=4018,,,4018.0,LPA,9606.0,Homo sapiens (human),[niacin co-treated with simvastatin] results in decreased expression of LPA protein,,,PMID:18471454,https://www.ncbi.nlm.nih.gov/pubmed/18471454,18471454,,
160,65376,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,4018,LPA,https://ctdbase.org/detail.go?type=gene&acc=4018,,,4018.0,LPA,9606.0,Homo sapiens (human),Niacin results in decreased expression of LPA protein,,,PMID:12099974|PMID:12200755|PMID:12685616|PMID:15159270,https://www.ncbi.nlm.nih.gov/pubmed/12099974|https://www.ncbi.nlm.nih.gov/pubmed/12200755|https://www.ncbi.nlm.nih.gov/pubmed/12685616|https://www.ncbi.nlm.nih.gov/pubmed/15159270,12099974|12200755|12685616|15159270,,
161,65377,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,4133,MAP2,https://ctdbase.org/detail.go?type=gene&acc=4133,,,4133.0,MAP2,10116.0,Rattus norvegicus (Norway rat),Niacin results in increased expression of MAP2 mRNA,,,PMID:20303128,https://www.ncbi.nlm.nih.gov/pubmed/20303128,20303128,,
162,65378,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,9606.0,Homo sapiens (human),Pertussis toxin inhibits the reaction [niacin results in increased phosphorylation of MAPK1 protein]|[niacin binds to and results in increased activity of HCAR3 protein] which results in increased phosphorylation of MAPK1 protein|[niacin binds to and results in increased activity of HCAR2 protein] which results in increased phosphorylation of MAPK1 protein,,,PMID:16389067,https://www.ncbi.nlm.nih.gov/pubmed/16389067,16389067,,
163,65379,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606.0,Homo sapiens (human),[niacin binds to and results in increased activity of HCAR3 protein] which results in increased phosphorylation of MAPK3 protein|[niacin binds to and results in increased activity of HCAR2 protein] which results in increased phosphorylation of MAPK3 protein|pertussis toxin inhibits the reaction [niacin results in increased phosphorylation of MAPK3 protein],,,PMID:16389067,https://www.ncbi.nlm.nih.gov/pubmed/16389067,16389067,,
164,65380,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,51085,MLXIPL,https://ctdbase.org/detail.go?type=gene&acc=51085,,,51085.0,MLXIPL,10116.0,Rattus norvegicus (Norway rat),Niacin results in decreased expression of MLXIPL protein,,,PMID:19878707,https://www.ncbi.nlm.nih.gov/pubmed/19878707,19878707,,
165,65381,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,4353,MPO,https://ctdbase.org/detail.go?type=gene&acc=4353,,,4353.0,MPO,9986.0,Oryctolagus cuniculus (rabbit),Niacin results in decreased expression of MPO protein,,,PMID:20167660,https://www.ncbi.nlm.nih.gov/pubmed/20167660,20167660,,
166,65382,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,2475,MTOR,https://ctdbase.org/detail.go?type=gene&acc=2475,,,2475.0,MTOR,10116.0,Rattus norvegicus (Norway rat),Niacin results in decreased phosphorylation of and results in decreased activity of MTOR protein,,,PMID:12837665,https://www.ncbi.nlm.nih.gov/pubmed/12837665,12837665,,
167,65516,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,653361,NCF1,https://ctdbase.org/detail.go?type=gene&acc=653361,,,653361.0,NCF1,10116.0,Rattus norvegicus (Norway rat),Niacin results in decreased expression of NCF1 protein,,,PMID:19420110,https://www.ncbi.nlm.nih.gov/pubmed/19420110,19420110,,
168,65517,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,10276,NET1,https://ctdbase.org/detail.go?type=gene&acc=10276,,,10276.0,NET1,10090.0,Mus musculus (house mouse),LEPR gene mutant form promotes the reaction [[niacin binds to chromium] which results in decreased expression of NET1 mrna],,,PMID:16940432,https://www.ncbi.nlm.nih.gov/pubmed/16940432,16940432,,
169,65518,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,4790,NFKB1,https://ctdbase.org/detail.go?type=gene&acc=4790,,,4790.0,NFKB1,10116.0,Rattus norvegicus (Norway rat),Niacin results in decreased expression of NFKB1 protein,,,PMID:19420110,https://www.ncbi.nlm.nih.gov/pubmed/19420110,19420110,,
170,65519,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,4792,NFKBIA,https://ctdbase.org/detail.go?type=gene&acc=4792,,,4792.0,NFKBIA,10116.0,Rattus norvegicus (Norway rat),"Niacin inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased phosphorylation of NFKBIA protein]|niacin inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in decreased expression of NFKBIA protein]",,,PMID:20975550,https://www.ncbi.nlm.nih.gov/pubmed/20975550,20975550,,
171,65520,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10116.0,Rattus norvegicus (Norway rat),Niacin inhibits the reaction [silicon dioxide results in increased expression of and results in increased activity of NOS2 protein],,,PMID:15182488,https://www.ncbi.nlm.nih.gov/pubmed/15182488,15182488,,
172,65521,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,4846,NOS3,https://ctdbase.org/detail.go?type=gene&acc=4846,,,4846.0,NOS3,10090.0,Mus musculus (house mouse),Niacin results in increased phosphorylation of NOS3 protein|niacin results in increased expression of NOS3 mRNA,,,PMID:17557352,https://www.ncbi.nlm.nih.gov/pubmed/17557352,17557352,,
173,65522,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,4846,NOS3,https://ctdbase.org/detail.go?type=gene&acc=4846,,,4846.0,NOS3,10116.0,Rattus norvegicus (Norway rat),[niacin co-treated with chromium] inhibits the reaction [CAV1 protein binds to NOS3 protein]|[niacin co-treated with chromium] results in increased phosphorylation of NOS3 protein,,,PMID:19027847,https://www.ncbi.nlm.nih.gov/pubmed/19027847,19027847,,
174,65523,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,4851,NOTCH1,https://ctdbase.org/detail.go?type=gene&acc=4851,,,4851.0,NOTCH1,10116.0,Rattus norvegicus (Norway rat),Niacin results in increased expression of NOTCH1 protein,,,PMID:19223914,https://www.ncbi.nlm.nih.gov/pubmed/19223914,19223914,,
175,65524,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,50507,NOX4,https://ctdbase.org/detail.go?type=gene&acc=50507,,,50507.0,NOX4,10116.0,Rattus norvegicus (Norway rat),Niacin results in decreased expression of NOX4 protein,,,PMID:19420110,https://www.ncbi.nlm.nih.gov/pubmed/19420110,19420110,,
176,65525,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,10062,NR1H3,https://ctdbase.org/detail.go?type=gene&acc=10062,,,10062.0,NR1H3,9606.0,Homo sapiens (human),Niacin results in increased expression of NR1H3 mrna|pparg protein promotes the reaction [niacin results in increased expression of NR1H3 mrna],,,PMID:15037193,https://www.ncbi.nlm.nih.gov/pubmed/15037193,15037193,,
177,65667,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,10062,NR1H3,https://ctdbase.org/detail.go?type=gene&acc=10062,,,10062.0,NR1H3,10090.0,Mus musculus (house mouse),Niacin results in increased expression of NR1H3 mrna|2-chloro-5-nitrobenzanilide inhibits the reaction [niacin results in increased expression of NR1H3 mrna]|pparg protein promotes the reaction [niacin results in increased expression of NR1H3 mrna],,,PMID:19797938,https://www.ncbi.nlm.nih.gov/pubmed/19797938,19797938,,
178,65668,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,10062,NR1H3,https://ctdbase.org/detail.go?type=gene&acc=10062,,,10062.0,NR1H3,9986.0,Oryctolagus cuniculus (rabbit),"Niacin inhibits the reaction [cholesterol, dietary results in decreased expression of NR1H3 mrna]|niacin inhibits the reaction [[cholesterol, dietary results in decreased expression of NR1H3 mrna] which results in decreased export of cholesterol]",,,PMID:17395297,https://www.ncbi.nlm.nih.gov/pubmed/17395297,17395297,,
179,65669,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,10062,NR1H3,https://ctdbase.org/detail.go?type=gene&acc=10062,,,10062.0,NR1H3,9986.0,Oryctolagus cuniculus (rabbit),Niacin inhibits the reaction [cholesterol results in decreased expression of NR1H3 mrna]|niacin inhibits the reaction [[cholesterol results in decreased expression of NR1H3 mrna] which results in decreased export of cholesterol],,,PMID:17963637,https://www.ncbi.nlm.nih.gov/pubmed/17963637,17963637,,
180,65670,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,10062,NR1H3,https://ctdbase.org/detail.go?type=gene&acc=10062,,,10062.0,NR1H3,9986.0,Oryctolagus cuniculus (rabbit),Niacin results in increased expression of NR1H3 mrna|[niacin results in increased expression of NR1H3 mrna] which results in increased export of cholesterol,,,PMID:17395297|PMID:17963637,https://www.ncbi.nlm.nih.gov/pubmed/17395297|https://www.ncbi.nlm.nih.gov/pubmed/17963637,17395297|17963637,,
181,65671,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,4892,NRAP,https://ctdbase.org/detail.go?type=gene&acc=4892,,,4892.0,NRAP,10090.0,Mus musculus (house mouse),LEPR gene mutant form promotes the reaction [[niacin binds to chromium] which results in increased expression of NRAP mrna],,,PMID:16940432,https://www.ncbi.nlm.nih.gov/pubmed/16940432,16940432,,
182,65672,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,4915,NTRK2,https://ctdbase.org/detail.go?type=gene&acc=4915,,,4915.0,NTRK2,10116.0,Rattus norvegicus (Norway rat),Niacin results in increased expression of NTRK2 protein,,,PMID:20671245,https://www.ncbi.nlm.nih.gov/pubmed/20671245,20671245,,
183,65673,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,4973,OLR1,https://ctdbase.org/detail.go?type=gene&acc=4973,,,4973.0,OLR1,10116.0,Rattus norvegicus (Norway rat),[niacin co-treated with chromium] inhibits the reaction [dietary fats results in increased expression of OLR1 mrna]|[niacin co-treated with chromium] inhibits the reaction [dietary fats results in increased expression of OLR1 protein],,,PMID:18622720,https://www.ncbi.nlm.nih.gov/pubmed/18622720,18622720,,
184,65674,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606.0,Homo sapiens (human),[niacin co-treated with ubiquinone co-treated with riboflavin] results in increased expression of PARP1 protein,,,PMID:18377693,https://www.ncbi.nlm.nih.gov/pubmed/18377693,18377693,,
185,65675,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,10116.0,Rattus norvegicus (Norway rat),Niacin deficiency affects the reaction [etoposide results in increased cleavage of PARP1 protein],,,PMID:17516866,https://www.ncbi.nlm.nih.gov/pubmed/17516866,17516866,,
186,65849,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,5105,PCK1,https://ctdbase.org/detail.go?type=gene&acc=5105,,,5105.0,PCK1,10090.0,Mus musculus (house mouse),LEPR gene mutant form promotes the reaction [[niacin binds to chromium] which results in decreased expression of PCK1 mrna],,,PMID:16940432,https://www.ncbi.nlm.nih.gov/pubmed/16940432,16940432,,
187,65850,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,5105,PCK1,https://ctdbase.org/detail.go?type=gene&acc=5105,,,5105.0,PCK1,10116.0,Rattus norvegicus (Norway rat),Niacin results in decreased expression of PCK1 mRNA,,,PMID:20303128,https://www.ncbi.nlm.nih.gov/pubmed/20303128,20303128,,
188,65851,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,5166,PDK4,https://ctdbase.org/detail.go?type=gene&acc=5166,,,5166.0,PDK4,10116.0,Rattus norvegicus (Norway rat),Niacin results in increased expression of PDK4 mRNA,,,PMID:20303128,https://www.ncbi.nlm.nih.gov/pubmed/20303128,20303128,,
189,65852,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,5175,PECAM1,https://ctdbase.org/detail.go?type=gene&acc=5175,,,5175.0,PECAM1,9606.0,Homo sapiens (human),Niacin inhibits the reaction [TNF protein results in increased expression of PECAM1 protein]|niacin results in decreased expression of PECAM1 protein,,,PMID:19159436,https://www.ncbi.nlm.nih.gov/pubmed/19159436,19159436,,
190,65853,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,221476,PI16,https://ctdbase.org/detail.go?type=gene&acc=221476,,,221476.0,PI16,10090.0,Mus musculus (house mouse),LEPR gene mutant form promotes the reaction [[niacin binds to chromium] which results in increased expression of PI16 mrna],,,PMID:16940432,https://www.ncbi.nlm.nih.gov/pubmed/16940432,16940432,,
191,65854,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,7941,PLA2G7,https://ctdbase.org/detail.go?type=gene&acc=7941,,,7941.0,PLA2G7,9606.0,Homo sapiens (human),Niacin results in decreased expression of PLA2G7 protein,,,PMID:16950175,https://www.ncbi.nlm.nih.gov/pubmed/16950175,16950175,,
192,65855,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,5465,PPARA,https://ctdbase.org/detail.go?type=gene&acc=5465,,,5465.0,PPARA,9606.0,Homo sapiens (human),Niacin results in increased expression of PPARA mRNA,,,PMID:18602814|PMID:24767308,https://www.ncbi.nlm.nih.gov/pubmed/18602814|https://www.ncbi.nlm.nih.gov/pubmed/24767308,18602814|24767308,,
193,65856,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,5465,PPARA,https://ctdbase.org/detail.go?type=gene&acc=5465,,,5465.0,PPARA,10116.0,Rattus norvegicus (Norway rat),Niacin results in increased expression of PPARA protein,,,PMID:19878707,https://www.ncbi.nlm.nih.gov/pubmed/19878707,19878707,,
194,65857,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9606.0,Homo sapiens (human),PTGDS protein promotes the reaction [niacin results in increased activity of PPARG protein]|aspirin inhibits the reaction [niacin results in increased activity of PPARG protein]|hcar2 protein promotes the reaction [niacin results in increased expression of and results in increased activity of PPARG protein]|hcar3 protein promotes the reaction [niacin results in increased activity of PPARG protein]|ptgs1 protein promotes the reaction [niacin results in increased activity of PPARG protein]|4-benzhydryloxy-1-(3-(1H-tetrazol-5-yl-)-propyl)piperidine inhibits the reaction [niacin results in increased activity of PPARG protein],,,PMID:16386710,https://www.ncbi.nlm.nih.gov/pubmed/16386710,16386710,,
195,65858,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9606.0,Homo sapiens (human),Niacin results in increased expression of and results in increased activity of PPARG protein,,,PMID:15037193|PMID:16386710,https://www.ncbi.nlm.nih.gov/pubmed/15037193|https://www.ncbi.nlm.nih.gov/pubmed/16386710,15037193|16386710,,
196,66015,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9606.0,Homo sapiens (human),Niacin results in increased expression of PPARG mRNA,,,PMID:15037193|PMID:19131065|PMID:24767308,https://www.ncbi.nlm.nih.gov/pubmed/15037193|https://www.ncbi.nlm.nih.gov/pubmed/19131065|https://www.ncbi.nlm.nih.gov/pubmed/24767308,15037193|19131065|24767308,,
197,66016,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9606.0,Homo sapiens (human),PPARG protein promotes the reaction [niacin results in increased expression of NR1H3 mrna],,,PMID:15037193,https://www.ncbi.nlm.nih.gov/pubmed/15037193,15037193,,
198,66017,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10090.0,Mus musculus (house mouse),[niacin results in decreased abundance of dinoprost] which results in increased expression of PPARG mrna|fluprostenol inhibits the reaction [niacin results in increased expression of PPARG mrna]|[niacin results in decreased abundance of dinoprost] which results in increased expression of PPARG protein,,,PMID:21236357,https://www.ncbi.nlm.nih.gov/pubmed/21236357,21236357,,
199,66018,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10090.0,Mus musculus (house mouse),PPARG protein promotes the reaction [niacin results in increased expression of NR1H3 mrna]|niacin results in increased expression of PPARG mrna|pparg protein promotes the reaction [niacin results in increased expression of ABCA1 mrna]|pparg protein promotes the reaction [niacin promotes the reaction [APOA1 protein results in increased export of cholesterol]],,,PMID:19797938,https://www.ncbi.nlm.nih.gov/pubmed/19797938,19797938,,
200,66019,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9986.0,Oryctolagus cuniculus (rabbit),Niacin inhibits the reaction [cholesterol results in decreased expression of PPARG mrna],,,PMID:18402819,https://www.ncbi.nlm.nih.gov/pubmed/18402819,18402819,,
201,66020,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9986.0,Oryctolagus cuniculus (rabbit),Niacin results in increased expression of PPARG mrna|[niacin results in increased expression of PPARG mrna] which results in increased export of cholesterol,,,PMID:17395297|PMID:17963637,https://www.ncbi.nlm.nih.gov/pubmed/17395297|https://www.ncbi.nlm.nih.gov/pubmed/17963637,17395297|17963637,,
202,66021,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,10891,PPARGC1A,https://ctdbase.org/detail.go?type=gene&acc=10891,,,10891.0,PPARGC1A,9606.0,Homo sapiens (human),Niacin results in increased expression of PPARGC1A mRNA,,,PMID:23056435,https://www.ncbi.nlm.nih.gov/pubmed/23056435,23056435,,
203,66022,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,5563,PRKAA2,https://ctdbase.org/detail.go?type=gene&acc=5563,,,5563.0,PRKAA2,9606.0,Homo sapiens (human),Niacin results in increased activity of PRKAA2 protein,,,PMID:14749208,https://www.ncbi.nlm.nih.gov/pubmed/14749208,14749208,,
204,66023,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,5729,PTGDR,https://ctdbase.org/detail.go?type=gene&acc=5729,,,5729.0,PTGDR,9606.0,Homo sapiens (human),[MK-0524 binds to and results in decreased activity of PTGDR protein] which results in decreased susceptibility to niacin,,,PMID:17392721,https://www.ncbi.nlm.nih.gov/pubmed/17392721,17392721,,
205,66024,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,5730,PTGDS,https://ctdbase.org/detail.go?type=gene&acc=5730,,,5730.0,PTGDS,9606.0,Homo sapiens (human),PTGDS protein promotes the reaction [niacin results in increased activity of PPARG protein],,,PMID:16386710,https://www.ncbi.nlm.nih.gov/pubmed/16386710,16386710,,
206,66163,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,5742,PTGS1,https://ctdbase.org/detail.go?type=gene&acc=5742,,,5742.0,PTGS1,9606.0,Homo sapiens (human),PTGS1 protein promotes the reaction [niacin results in increased activity of PPARG protein],,,PMID:16386710,https://www.ncbi.nlm.nih.gov/pubmed/16386710,16386710,,
207,66164,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,5742,PTGS1,https://ctdbase.org/detail.go?type=gene&acc=5742,,,5742.0,PTGS1,10090.0,Mus musculus (house mouse),PTGS1 protein results in increased susceptibility to niacin,,,PMID:16322797,https://www.ncbi.nlm.nih.gov/pubmed/16322797,16322797,,
208,66165,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,5742,PTGS1,https://ctdbase.org/detail.go?type=gene&acc=5742,,,5742.0,PTGS1,10116.0,Rattus norvegicus (Norway rat),Niacin results in decreased expression of PTGS1 protein,,,PMID:19420110,https://www.ncbi.nlm.nih.gov/pubmed/19420110,19420110,,
209,66166,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10090.0,Mus musculus (house mouse),Niacin inhibits the reaction [CEBPB protein binds to PTGS2 promoter]|niacin results in decreased expression of PTGS2 protein|niacin results in decreased expression of PTGS2 mrna|[niacin results in decreased expression of PTGS2 mrna] which results in decreased abundance of dinoprost,,,PMID:21236357,https://www.ncbi.nlm.nih.gov/pubmed/21236357,21236357,,
210,66167,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10090.0,Mus musculus (house mouse),[niacin inhibits the reaction [CEBPB protein binds to PTGS2 promoter]] which results in decreased expression of PTGS2 mRNA,,,PMID:21236357,https://www.ncbi.nlm.nih.gov/pubmed/21236357,21236357|21236357,,
211,66168,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,23475,QPRT,https://ctdbase.org/detail.go?type=gene&acc=23475,,,23475.0,QPRT,10116.0,Rattus norvegicus (Norway rat),QPRT protein results in increased abundance of niacin,,,PMID:11758903,https://www.ncbi.nlm.nih.gov/pubmed/11758903,11758903,,
212,66169,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,253959,RALGAPA1,https://ctdbase.org/detail.go?type=gene&acc=253959,,,253959.0,RALGAPA1,10090.0,Mus musculus (house mouse),LEPR gene mutant form promotes the reaction [[niacin binds to chromium] which results in increased expression of RALGAPA1 mrna],,,PMID:16940432,https://www.ncbi.nlm.nih.gov/pubmed/16940432,16940432,,
213,66170,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,9606.0,Homo sapiens (human),Niacin inhibits the reaction [TNF protein results in increased activity of RELA protein],,,PMID:18550065,https://www.ncbi.nlm.nih.gov/pubmed/18550065,18550065,,
214,66171,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10116.0,Rattus norvegicus (Norway rat),"Niacin inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of and results in increased activity of RELA protein]",,,PMID:20975550,https://www.ncbi.nlm.nih.gov/pubmed/20975550,20975550,,
215,66172,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10116.0,Rattus norvegicus (Norway rat),Niacin results in decreased expression of RELA protein,,,PMID:19420110,https://www.ncbi.nlm.nih.gov/pubmed/19420110,19420110,,
216,66342,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,56729,RETN,https://ctdbase.org/detail.go?type=gene&acc=56729,,,56729.0,RETN,9606.0,Homo sapiens (human),Niacin results in decreased expression of RETN protein,,,PMID:16979396,https://www.ncbi.nlm.nih.gov/pubmed/16979396,16979396,,
217,66343,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,6198,RPS6KB1,https://ctdbase.org/detail.go?type=gene&acc=6198,,,6198.0,RPS6KB1,10116.0,Rattus norvegicus (Norway rat),Niacin results in decreased phosphorylation of and results in decreased activity of RPS6KB1 protein,,,PMID:12837665,https://www.ncbi.nlm.nih.gov/pubmed/12837665,12837665,,
218,66344,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,65078,RTN4R,https://ctdbase.org/detail.go?type=gene&acc=65078,,,65078.0,RTN4R,10116.0,Rattus norvegicus (Norway rat),Niacin results in decreased expression of RTN4R protein,,,PMID:20671245,https://www.ncbi.nlm.nih.gov/pubmed/20671245,20671245,,
219,66345,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,949,SCARB1,https://ctdbase.org/detail.go?type=gene&acc=949,,,949.0,SCARB1,9606.0,Homo sapiens (human),Aspirin inhibits the reaction [niacin results in increased expression of SCARB1 mrna]|niacin results in increased expression of SCARB1 mrna|ro 31-8220 inhibits the reaction [niacin results in increased expression of SCARB1 mrna],,,PMID:15037193,https://www.ncbi.nlm.nih.gov/pubmed/15037193,15037193,,
220,66346,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,949,SCARB1,https://ctdbase.org/detail.go?type=gene&acc=949,,,949.0,SCARB1,9606.0,Homo sapiens (human),"Niacin promotes the reaction [SCARB1 protein results in increased export of cholesterol, HDL]",,,PMID:21291703,https://www.ncbi.nlm.nih.gov/pubmed/21291703,21291703,,
221,66347,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,949,SCARB1,https://ctdbase.org/detail.go?type=gene&acc=949,,,949.0,SCARB1,10116.0,Rattus norvegicus (Norway rat),Niacin results in decreased expression of SCARB1 protein,,,PMID:19878707,https://www.ncbi.nlm.nih.gov/pubmed/19878707,19878707,,
222,66348,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,5054,SERPINE1,https://ctdbase.org/detail.go?type=gene&acc=5054,,,5054.0,SERPINE1,9606.0,Homo sapiens (human),Niacin inhibits the reaction [TGFB1 protein results in increased expression of SERPINE1 protein],,,PMID:16916501,https://www.ncbi.nlm.nih.gov/pubmed/16916501,16916501,,
223,66349,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,5054,SERPINE1,https://ctdbase.org/detail.go?type=gene&acc=5054,,,5054.0,SERPINE1,10116.0,Rattus norvegicus (Norway rat),Niacin results in decreased expression of SERPINE1 protein,,,PMID:19420110,https://www.ncbi.nlm.nih.gov/pubmed/19420110,19420110,,
224,66350,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,22933,SIRT2,https://ctdbase.org/detail.go?type=gene&acc=22933,,,22933.0,SIRT2,9606.0,Homo sapiens (human),Niacin deficiency results in increased expression of SIRT2 mRNA,,,PMID:22860104,https://www.ncbi.nlm.nih.gov/pubmed/22860104,22860104,,
225,66351,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,23409,SIRT4,https://ctdbase.org/detail.go?type=gene&acc=23409,,,23409.0,SIRT4,9606.0,Homo sapiens (human),Niacin deficiency results in increased expression of SIRT4 mRNA,,,PMID:22860104,https://www.ncbi.nlm.nih.gov/pubmed/22860104,22860104,,
226,66352,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,6566,SLC16A1,https://ctdbase.org/detail.go?type=gene&acc=6566,,,6566.0,SLC16A1,10116.0,Rattus norvegicus (Norway rat),SLC16A1 protein results in increased import of niacin,,,PMID:10579682,https://www.ncbi.nlm.nih.gov/pubmed/10579682,10579682,,
227,66536,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,10864,SLC22A7,https://ctdbase.org/detail.go?type=gene&acc=10864,,,10864.0,SLC22A7,9606.0,Homo sapiens (human),Niacin promotes the reaction [SLC22A7 protein results in increased export of orotic acid],,,PMID:22981274,https://www.ncbi.nlm.nih.gov/pubmed/22981274,22981274,,
228,66537,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,11001,SLC27A2,https://ctdbase.org/detail.go?type=gene&acc=11001,,,11001.0,SLC27A2,9606.0,Homo sapiens (human),Niacin results in increased expression of SLC27A2 mRNA,,,PMID:24767308,https://www.ncbi.nlm.nih.gov/pubmed/24767308,24767308,,
229,66538,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,10999,SLC27A4,https://ctdbase.org/detail.go?type=gene&acc=10999,,,10999.0,SLC27A4,9606.0,Homo sapiens (human),Niacin results in increased expression of SLC27A4 mRNA,,,PMID:24767308,https://www.ncbi.nlm.nih.gov/pubmed/24767308,24767308,,
230,66539,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,6517,SLC2A4,https://ctdbase.org/detail.go?type=gene&acc=6517,,,6517.0,SLC2A4,10116.0,Rattus norvegicus (Norway rat),[niacin co-treated with chromium] results in increased localization of SLC2A4 protein|[niacin co-treated with chromium] promotes the reaction [SLC2A4 protein binds to CAV3 protein],,,PMID:19027847,https://www.ncbi.nlm.nih.gov/pubmed/19027847,19027847,,
231,66540,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,6522,SLC4A2,https://ctdbase.org/detail.go?type=gene&acc=6522,,,6522.0,SLC4A2,10090.0,Mus musculus (house mouse),SLC4A2 protein results in increased uptake of niacin,,,PMID:9563070,https://www.ncbi.nlm.nih.gov/pubmed/9563070,9563070,,
232,66541,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,6622,SNCA,https://ctdbase.org/detail.go?type=gene&acc=6622,,,6622.0,SNCA,10090.0,Mus musculus (house mouse),Niacin inhibits the reaction [rotenone results in increased expression of SNCA protein]|[curcumin co-treated with niacin co-treated with ZM 241385] inhibits the reaction [rotenone results in increased expression of SNCA protein],,,PMID:31820278,https://www.ncbi.nlm.nih.gov/pubmed/31820278,31820278,,
233,66542,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,11005,SPINK5,https://ctdbase.org/detail.go?type=gene&acc=11005,,,11005.0,SPINK5,10116.0,Rattus norvegicus (Norway rat),Niacin results in increased expression of SPINK5 mRNA,,,PMID:20303128,https://www.ncbi.nlm.nih.gov/pubmed/20303128,20303128,,
234,66543,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,6345,SRL,https://ctdbase.org/detail.go?type=gene&acc=6345,,,6345.0,SRL,10090.0,Mus musculus (house mouse),LEPR gene mutant form promotes the reaction [[niacin binds to chromium] which results in increased expression of SRL mrna],,,PMID:16940432,https://www.ncbi.nlm.nih.gov/pubmed/16940432,16940432,,
235,66544,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,6480,ST6GAL1,https://ctdbase.org/detail.go?type=gene&acc=6480,,,6480.0,ST6GAL1,10116.0,Rattus norvegicus (Norway rat),Niacin results in increased expression of ST6GAL1 mRNA,,,PMID:20303128,https://www.ncbi.nlm.nih.gov/pubmed/20303128,20303128,,
236,66545,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,6770,STAR,https://ctdbase.org/detail.go?type=gene&acc=6770,,,6770.0,STAR,10116.0,Rattus norvegicus (Norway rat),[niacin co-treated with chromium] results in increased expression of STAR protein|[[niacin co-treated with chromium] results in increased expression of STAR protein] which results in increased export of cholesterol,,,PMID:17934701,https://www.ncbi.nlm.nih.gov/pubmed/17934701,17934701,,
237,66723,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,6776,STAT5A,https://ctdbase.org/detail.go?type=gene&acc=6776,,,6776.0,STAT5A,10116.0,Rattus norvegicus (Norway rat),Niacin results in decreased activity of STAT5A protein,,,PMID:15746188,https://www.ncbi.nlm.nih.gov/pubmed/15746188,15746188,,
238,66724,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,6855,SYP,https://ctdbase.org/detail.go?type=gene&acc=6855,,,6855.0,SYP,10116.0,Rattus norvegicus (Norway rat),Niacin results in increased expression of SYP protein,,,PMID:20671245,https://www.ncbi.nlm.nih.gov/pubmed/20671245,20671245,,
239,66725,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,7010,TEK,https://ctdbase.org/detail.go?type=gene&acc=7010,,,7010.0,TEK,10116.0,Rattus norvegicus (Norway rat),Niacin results in increased expression of TEK mrna|niacin results in increased phosphorylation of TEK protein,,,PMID:17557352,https://www.ncbi.nlm.nih.gov/pubmed/17557352,17557352,,
240,66726,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,54997,TESC,https://ctdbase.org/detail.go?type=gene&acc=54997,,,54997.0,TESC,10116.0,Rattus norvegicus (Norway rat),Niacin results in increased expression of TESC mRNA,,,PMID:20303128,https://www.ncbi.nlm.nih.gov/pubmed/20303128,20303128,,
241,66727,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,7037,TFRC,https://ctdbase.org/detail.go?type=gene&acc=7037,,,7037.0,TFRC,10116.0,Rattus norvegicus (Norway rat),Niacin results in decreased expression of TFRC protein,,,PMID:18549825,https://www.ncbi.nlm.nih.gov/pubmed/18549825,18549825,,
242,66728,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040.0,TGFB1,9606.0,Homo sapiens (human),Niacin inhibits the reaction [silicon dioxide results in increased expression of TGFB1 protein]|niacin inhibits the reaction [silicon dioxide results in increased expression of TGFB1 mrna],,,PMID:19337903,https://www.ncbi.nlm.nih.gov/pubmed/19337903,19337903,,
243,66729,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040.0,TGFB1,9606.0,Homo sapiens (human),Niacin inhibits the reaction [TGFB1 protein results in increased expression of SERPINE1 protein],,,PMID:16916501,https://www.ncbi.nlm.nih.gov/pubmed/16916501,16916501,,
244,66730,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040.0,TGFB1,10116.0,Rattus norvegicus (Norway rat),Niacin results in decreased expression of TGFB1 protein,,,PMID:19420110,https://www.ncbi.nlm.nih.gov/pubmed/19420110,19420110,,
245,66731,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,7094,TLN1,https://ctdbase.org/detail.go?type=gene&acc=7094,,,7094.0,TLN1,10090.0,Mus musculus (house mouse),LEPR gene mutant form promotes the reaction [[niacin binds to chromium] which results in increased expression of TLN1 mrna],,,PMID:16940432,https://www.ncbi.nlm.nih.gov/pubmed/16940432,16940432,,
246,66732,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),Niacin inhibits the reaction [TNF protein results in increased expression of VCAM1 mrna]|niacin inhibits the reaction [TNF protein results in increased expression of CCL2 protein]|niacin inhibits the reaction [TNF protein results in increased activity of RELA protein],,,PMID:18550065,https://www.ncbi.nlm.nih.gov/pubmed/18550065,18550065,,
247,66918,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),Niacin inhibits the reaction [TNF protein results in increased expression of ICAM1 mrna],,,PMID:16916501|PMID:19159436,https://www.ncbi.nlm.nih.gov/pubmed/16916501|https://www.ncbi.nlm.nih.gov/pubmed/19159436,16916501|19159436,,
248,66919,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),Niacin inhibits the reaction [TNF protein results in increased expression of PECAM1 protein],,,PMID:19159436,https://www.ncbi.nlm.nih.gov/pubmed/19159436,19159436,,
249,66920,938,Comparative Toxicogenomics Database (CTD),Nicotinic acid,D009525,Niacin,https://ctdbase.org/detail.go?type=chem&acc=D009525,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),[ubiquinone co-treated with niacin co-treated with riboflavin] promotes the reaction [tamoxifen results in decreased expression of TNF protein],,,PMID:17516992,https://www.ncbi.nlm.nih.gov/pubmed/17516992,17516992,,
250,71514,938,Drug Gene Interaction database (DGIdb),Nicotinic acid,,NIACIN,https://www.dgidb.org/drugs/NIACIN,,CYP2D6,https://www.dgidb.org/genes/CYP2D6,,,1565.0,CYP2D6,9606.0,Homo sapiens (human),,,,PMID:22931300,https://www.ncbi.nlm.nih.gov/pubmed/22931300,22931300,,
251,81178,938,Drug Gene Interaction database (DGIdb),Nicotinic acid,,NIACIN,https://www.dgidb.org/drugs/NIACIN,,HCAR3,https://www.dgidb.org/genes/HCAR3,,,8843.0,HCAR3,9606.0,Homo sapiens (human),,,,,,,,
252,100413,938,Drug Gene Interaction database (DGIdb),Nicotinic acid,,NIACIN,https://www.dgidb.org/drugs/NIACIN,,HCAR2,https://www.dgidb.org/genes/HCAR2,,,338442.0,HCAR2,9606.0,Homo sapiens (human),,,,PMID:25737085,https://www.ncbi.nlm.nih.gov/pubmed/25737085,25737085,,
253,106967,938,Toxin and Toxin Target Database (T3DB),Nicotinic acid,T3D2841,Nicotinic acid,http://www.t3db.ca/toxins/T3D2841,BE0000635,Hydroxycarboxylic acid receptor 2,http://www.t3db.ca/biodb/bio_entities/BE0000635,Q8TDS4,Hydroxycarboxylic acid receptor 2,338442.0,HCAR2,9606.0,Homo sapiens (human),"Niacin binds to nicotinate D-ribonucleotide phyrophsopate phosphoribosyltransferase, nicotinic acid phosphoribosyltransferase, nicotinate N-methyltransferase and the niacin receptor. niacin is the precursor to nicotinamide adenine dinucleotide (NAD) and nicotinamide adenine dinucleotide phosphate (NADP), which are vital cofactors for dozens of enzymes. the mechanism by which niacin exerts its lipid lowering effects is not entirely understood, but may involve several actions, including a decrease in esterification of hepatic triglycerides. niacin treatment also decreases the serum levels of apolipoprotein B-100 (apo B), the major protein component of the VLDL (very low-density lipoprotein) and LDL fractions. (A1386, A1387, A1388, A1380, A1381)",,,PMID:16018973|PMID:16099840|PMID:12522134|PMID:12646212|PMID:15580557|PMID:18760600|PMID:17994679|PMID:18029181|PMID:19307116|PMID:19309152|PMID:19592242|PMID:20444602|PMID:20452209|PMID:20615702|PMID:18752940|PMID:17452318|PMID:18665582|PMID:20184326|PMID:16389067|PMID:20380810|PMID:20460384|PMID:21167710,https://www.ncbi.nlm.nih.gov/pubmed/16018973|https://www.ncbi.nlm.nih.gov/pubmed/16099840|https://www.ncbi.nlm.nih.gov/pubmed/12522134|https://www.ncbi.nlm.nih.gov/pubmed/12646212|https://www.ncbi.nlm.nih.gov/pubmed/15580557|https://www.ncbi.nlm.nih.gov/pubmed/18760600|https://www.ncbi.nlm.nih.gov/pubmed/17994679|https://www.ncbi.nlm.nih.gov/pubmed/18029181|https://www.ncbi.nlm.nih.gov/pubmed/19307116|https://www.ncbi.nlm.nih.gov/pubmed/19309152|https://www.ncbi.nlm.nih.gov/pubmed/19592242|https://www.ncbi.nlm.nih.gov/pubmed/20444602|https://www.ncbi.nlm.nih.gov/pubmed/20452209|https://www.ncbi.nlm.nih.gov/pubmed/20615702|https://www.ncbi.nlm.nih.gov/pubmed/18752940|https://www.ncbi.nlm.nih.gov/pubmed/17452318|https://www.ncbi.nlm.nih.gov/pubmed/18665582|https://www.ncbi.nlm.nih.gov/pubmed/20184326|https://www.ncbi.nlm.nih.gov/pubmed/16389067|https://www.ncbi.nlm.nih.gov/pubmed/20380810|https://www.ncbi.nlm.nih.gov/pubmed/20460384|https://www.ncbi.nlm.nih.gov/pubmed/21167710,16018973|16099840|12522134|12646212|15580557|18760600|17994679|18029181|19307116|19309152|19592242|20444602|20452209|20615702|18752940|17452318|18665582|20184326|16389067|20380810|20460384|21167710,,
254,106968,938,Toxin and Toxin Target Database (T3DB),Nicotinic acid,T3D2841,Nicotinic acid,http://www.t3db.ca/toxins/T3D2841,BE0000836,Hydroxycarboxylic acid receptor 3,http://www.t3db.ca/biodb/bio_entities/BE0000836,P49019,Hydroxycarboxylic acid receptor 3,8843.0,HCAR3,9606.0,Homo sapiens (human),"Niacin binds to nicotinate D-ribonucleotide phyrophsopate phosphoribosyltransferase, nicotinic acid phosphoribosyltransferase, nicotinate N-methyltransferase and the niacin receptor. niacin is the precursor to nicotinamide adenine dinucleotide (NAD) and nicotinamide adenine dinucleotide phosphate (NADP), which are vital cofactors for dozens of enzymes. the mechanism by which niacin exerts its lipid lowering effects is not entirely understood, but may involve several actions, including a decrease in esterification of hepatic triglycerides. niacin treatment also decreases the serum levels of apolipoprotein B-100 (apo B), the major protein component of the VLDL (very low-density lipoprotein) and LDL fractions. (A1378, A1379, A1380, A1381, A1382)",,,PMID:12563315|PMID:15929991|PMID:16018973|PMID:16099840|PMID:16322797|PMID:16389067,https://www.ncbi.nlm.nih.gov/pubmed/12563315|https://www.ncbi.nlm.nih.gov/pubmed/15929991|https://www.ncbi.nlm.nih.gov/pubmed/16018973|https://www.ncbi.nlm.nih.gov/pubmed/16099840|https://www.ncbi.nlm.nih.gov/pubmed/16322797|https://www.ncbi.nlm.nih.gov/pubmed/16389067,12563315|15929991|16018973|16099840|16322797|16389067,,
255,107111,938,Toxin and Toxin Target Database (T3DB),Nicotinic acid,T3D2841,Nicotinic acid,http://www.t3db.ca/toxins/T3D2841,BE0000526,Nicotinate-nucleotide pyrophosphorylase [carboxylating],http://www.t3db.ca/biodb/bio_entities/BE0000526,Q15274,Nicotinate-nucleotide pyrophosphorylase [carboxylating],23475.0,QPRT,9606.0,Homo sapiens (human),"Niacin binds to nicotinate D-ribonucleotide phyrophsopate phosphoribosyltransferase, nicotinic acid phosphoribosyltransferase, nicotinate N-methyltransferase and the niacin receptor. niacin is the precursor to nicotinamide adenine dinucleotide (NAD) and nicotinamide adenine dinucleotide phosphate (NADP), which are vital cofactors for dozens of enzymes. the mechanism by which niacin exerts its lipid lowering effects is not entirely understood, but may involve several actions, including a decrease in esterification of hepatic triglycerides. niacin treatment also decreases the serum levels of apolipoprotein B-100 (apo B), the major protein component of the VLDL (very low-density lipoprotein) and LDL fractions. (A1383, A1384, A1385)",,,PMID:11758903|PMID:15753098|PMID:15837705,https://www.ncbi.nlm.nih.gov/pubmed/11758903|https://www.ncbi.nlm.nih.gov/pubmed/15753098|https://www.ncbi.nlm.nih.gov/pubmed/15837705,11758903|15753098|15837705,,
256,107112,938,Toxin and Toxin Target Database (T3DB),Nicotinic acid,T3D2841,Nicotinic acid,http://www.t3db.ca/toxins/T3D2841,BE0000783,Nicotinamide N-methyltransferase,http://www.t3db.ca/biodb/bio_entities/BE0000783,P40261,Nicotinamide N-methyltransferase,4837.0,NNMT,9606.0,Homo sapiens (human),"Niacin binds to nicotinate D-ribonucleotide phyrophsopate phosphoribosyltransferase, nicotinic acid phosphoribosyltransferase, nicotinate N-methyltransferase and the niacin receptor. niacin is the precursor to nicotinamide adenine dinucleotide (NAD) and nicotinamide adenine dinucleotide phosphate (NADP), which are vital cofactors for dozens of enzymes. the mechanism by which niacin exerts its lipid lowering effects is not entirely understood, but may involve several actions, including a decrease in esterification of hepatic triglycerides. niacin treatment also decreases the serum levels of apolipoprotein B-100 (apo B), the major protein component of the VLDL (very low-density lipoprotein) and LDL fractions. (A358, A359)",,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
257,112173,938,Therapeutic Target Database (TTD),Nicotinic acid,D0N0ES,Vitamin B3,https://idrblab.net/ttd/data/drug/details/D0N0ES,T95558,Diacylglycerol O-acyltransferase 2 (DGAT2),https://idrblab.net/ttd/data/target/details/T95558,Q96PD7,Diacylglycerol O-acyltransferase 2,84649.0,DGAT2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
258,112174,938,Therapeutic Target Database (TTD),Nicotinic acid,D0N0ES,Vitamin B3,https://idrblab.net/ttd/data/drug/details/D0N0ES,T88185,Nicotinic acid receptor (HCAR2),https://idrblab.net/ttd/data/target/details/T88185,Q8TDS4,Hydroxycarboxylic acid receptor 2,338442.0,HCAR2,9606.0,Homo sapiens (human),Agonist,,,,,,,
259,123109,938,Drug Gene Interaction database (DGIdb),Nicotinic acid,,NIACIN,https://www.dgidb.org/drugs/NIACIN,,HCAR2,https://www.dgidb.org/genes/HCAR2,,,338442.0,HCAR2,9606.0,Homo sapiens (human),,,,,,,,
260,125377,938,IUPHAR/BPS Guide to PHARMACOLOGY,Nicotinic acid,1588,nicotinic acid,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1588,311,HCA1 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=311,Q9BXC0,Hydroxycarboxylic acid receptor 1,27198.0,HCAR1,9606.0,Homo sapiens (human),Agonist,,7.13,PMID:12522134,https://www.ncbi.nlm.nih.gov/pubmed/12522134,12522134,,
261,125378,938,IUPHAR/BPS Guide to PHARMACOLOGY,Nicotinic acid,1594,[3H]nicotinic acid,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1594,312,HCA2 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=312,Q8TDS4,Hydroxycarboxylic acid receptor 2,338442.0,HCAR2,9606.0,Homo sapiens (human),Full agonist,pKd,7 - 7.3,PMID:12522134|PMID:12563315|PMID:12646212,https://www.ncbi.nlm.nih.gov/pubmed/12522134|https://www.ncbi.nlm.nih.gov/pubmed/12563315|https://www.ncbi.nlm.nih.gov/pubmed/12646212,12522134|12563315|12646212,,
262,125379,938,IUPHAR/BPS Guide to PHARMACOLOGY,Nicotinic acid,1588,nicotinic acid,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1588,312,HCA2 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=312,Q8TDS4,Hydroxycarboxylic acid receptor 2,338442.0,HCAR2,9606.0,Homo sapiens (human),Full agonist,pEC50,6 - 7.2,PMID:12522134|PMID:12563315|PMID:12646212,https://www.ncbi.nlm.nih.gov/pubmed/12522134|https://www.ncbi.nlm.nih.gov/pubmed/12563315|https://www.ncbi.nlm.nih.gov/pubmed/12646212,12522134|12563315|12646212,,
263,125380,938,IUPHAR/BPS Guide to PHARMACOLOGY,Nicotinic acid,1588,nicotinic acid,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1588,313,HCA3 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=313,P49019,Hydroxycarboxylic acid receptor 3,8843.0,HCAR3,9606.0,Homo sapiens (human),Full agonist,pEC50,4 - 6.52,PMID:12522134,https://www.ncbi.nlm.nih.gov/pubmed/12522134,12522134,,
264,189319,938,Drug Gene Interaction database (DGIdb),Nicotinic acid,,NIACIN,https://www.dgidb.org/drugs/NIACIN,,CYP2C9,https://www.dgidb.org/genes/CYP2C9,,,1559.0,CYP2C9,9606.0,Homo sapiens (human),,,,PMID:22931300,https://www.ncbi.nlm.nih.gov/pubmed/22931300,22931300,,
265,278762,938,DrugBank,Nicotinic acid,DB00627,Niacin,https://www.drugbank.ca/drugs/DB00627,BE0000635,Hydroxycarboxylic acid receptor 2,https://www.drugbank.ca/bio_entities/BE0000635,Q8TDS4,Hydroxycarboxylic acid receptor 2,338442.0,HCAR2,9606.0,Homo sapiens (human),Agonist,,,PMID:12522134|PMID:12646212|PMID:15580557|PMID:16018973|PMID:16099840,https://www.ncbi.nlm.nih.gov/pubmed/12522134|https://www.ncbi.nlm.nih.gov/pubmed/12646212|https://www.ncbi.nlm.nih.gov/pubmed/15580557|https://www.ncbi.nlm.nih.gov/pubmed/16018973|https://www.ncbi.nlm.nih.gov/pubmed/16099840,12522134|12646212|15580557|16018973|16099840,,"Wise A, Foord SM, Fraser NJ, Barnes AA, Elshourbagy N, Eilert M, Ignar DM, Murdock PR, Steplewski K, Green A, Brown AJ, Dowell SJ, Szekeres PG, Hassall DG, Marshall FH, Wilson S, Pike NB: Molecular identification of high and low affinity receptors for nicotinic acid. J Biol Chem. 2003 Mar 14;278(11):9869-74. Epub 2003 Jan 9.|Soga T, Kamohara M, Takasaki J, Matsumoto S, Saito T, Ohishi T, Hiyama H, Matsuo A, Matsushime H, Furuichi K: Molecular identification of nicotinic acid receptor. Biochem Biophys Res Commun. 2003 Mar 28;303(1):364-9.|Zellner C, Pullinger CR, Aouizerat BE, Frost PH, Kwok PY, Malloy MJ, Kane JP: Variations in human HM74 (GPR109B) and HM74A (GPR109A) niacin receptors. Hum Mutat. 2005 Jan;25(1):18-21.|Zhang Y, Schmidt RJ, Foxworthy P, Emkey R, Oler JK, Large TH, Wang H, Su EW, Mosior MK, Eacho PI, Cao G: Niacin mediates lipolysis in adipose tissue through its G-protein coupled receptor HM74A. Biochem Biophys Res Commun. 2005 Aug 26;334(2):729-32.|Tunaru S, Lattig J, Kero J, Krause G, Offermanns S: Characterization of determinants of ligand binding to the nicotinic acid receptor GPR109A (HM74A/PUMA-G). Mol Pharmacol. 2005 Nov;68(5):1271-80. Epub 2005 Aug 11."
266,278763,938,DrugBank,Nicotinic acid,DB00627,Niacin,https://www.drugbank.ca/drugs/DB00627,BE0000526,Nicotinate-nucleotide pyrophosphorylase [carboxylating],https://www.drugbank.ca/bio_entities/BE0000526,Q15274,Nicotinate-nucleotide pyrophosphorylase [carboxylating],23475.0,QPRT,9606.0,Homo sapiens (human),Binder,,,PMID:11758903|PMID:15753098|PMID:15837705,https://www.ncbi.nlm.nih.gov/pubmed/11758903|https://www.ncbi.nlm.nih.gov/pubmed/15753098|https://www.ncbi.nlm.nih.gov/pubmed/15837705,11758903|15753098|15837705,,"Fukuwatari T, Morikawa Y, Hayakawa F, Sugimoto E, Shibata K: Influence of adenine-induced renal failure on tryptophan-niacin metabolism in rats. Biosci Biotechnol Biochem. 2001 Oct;65(10):2154-61.|Shin DH, Oganesyan N, Jancarik J, Yokota H, Kim R, Kim SH: Crystal structure of a nicotinate phosphoribosyltransferase from Thermoplasma acidophilum. J Biol Chem. 2005 May 6;280(18):18326-35. Epub 2005 Mar 6.|Zheng XQ, Hayashibe E, Ashihara H: Changes in trigonelline (N-methylnicotinic acid) content and nicotinic acid metabolism during germination of mungbean (Phaseolus aureus) seeds. J Exp Bot. 2005 Jun;56(416):1615-23. Epub 2005 Apr 18."
267,278985,938,DrugBank,Nicotinic acid,DB00627,Niacin,https://www.drugbank.ca/drugs/DB00627,BE0000783,Nicotinamide N-methyltransferase,https://www.drugbank.ca/bio_entities/BE0000783,P40261,Nicotinamide N-methyltransferase,4837.0,NNMT,9606.0,Homo sapiens (human),Binder,,,PMID:17139284|PMID:17016423|PMID:18996527,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/18996527,17139284|17016423|18996527,,"Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.|Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.|Riederer M, Erwa W, Zimmermann R, Frank S, Zechner R: Adipose tissue as a source of nicotinamide N-methyltransferase and homocysteine. Atherosclerosis. 2009 Jun;204(2):412-7. doi: 10.1016/j.atherosclerosis.2008.09.015. Epub 2008 Sep 27."
268,278986,938,DrugBank,Nicotinic acid,DB00627,Niacin,https://www.drugbank.ca/drugs/DB00627,BE0002363,Cytochrome P450 2D6,https://www.drugbank.ca/bio_entities/BE0002363,P10635,Cytochrome P450 2D6,1565.0,CYP2D6,9606.0,Homo sapiens (human),Inhibitor,,,PMID:15081432,https://www.ncbi.nlm.nih.gov/pubmed/15081432,15081432,,"Gaudineau C, Auclair K: Inhibition of human P450 enzymes by nicotinic acid and nicotinamide. Biochem Biophys Res Commun. 2004 May 7;317(3):950-6. doi: 10.1016/j.bbrc.2004.03.137."
269,278987,938,DrugBank,Nicotinic acid,DB00627,Niacin,https://www.drugbank.ca/drugs/DB00627,BE0002638,Cytochrome P450 3A4,https://www.drugbank.ca/bio_entities/BE0002638,P08684,Cytochrome P450 3A4,1576.0,CYP3A4,9606.0,Homo sapiens (human),Inhibitor,,,PMID:15081432,https://www.ncbi.nlm.nih.gov/pubmed/15081432,15081432,,"Gaudineau C, Auclair K: Inhibition of human P450 enzymes by nicotinic acid and nicotinamide. Biochem Biophys Res Commun. 2004 May 7;317(3):950-6. doi: 10.1016/j.bbrc.2004.03.137."
270,278988,938,DrugBank,Nicotinic acid,DB00627,Niacin,https://www.drugbank.ca/drugs/DB00627,BE0003533,Cytochrome P450 2E1,https://www.drugbank.ca/bio_entities/BE0003533,P05181,Cytochrome P450 2E1,1571.0,CYP2E1,9606.0,Homo sapiens (human),Inhibitor,,,PMID:15081432,https://www.ncbi.nlm.nih.gov/pubmed/15081432,15081432,,"Gaudineau C, Auclair K: Inhibition of human P450 enzymes by nicotinic acid and nicotinamide. Biochem Biophys Res Commun. 2004 May 7;317(3):950-6. doi: 10.1016/j.bbrc.2004.03.137."
271,278989,938,DrugBank,Nicotinic acid,DB00627,Niacin,https://www.drugbank.ca/drugs/DB00627,BE0000106,Solute carrier family 22 member 5,https://www.drugbank.ca/bio_entities/BE0000106,O76082,Solute carrier family 22 member 5,6584.0,SLC22A5,9606.0,Homo sapiens (human),Inhibitor,,,PMID:10525100,https://www.ncbi.nlm.nih.gov/pubmed/10525100,10525100,,"Ohashi R, Tamai I, Yabuuchi H, Nezu JI, Oku A, Sai Y, Shimane M, Tsuji A: Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance. J Pharmacol Exp Ther. 1999 Nov;291(2):778-84."
272,278990,938,DrugBank,Nicotinic acid,DB00627,Niacin,https://www.drugbank.ca/drugs/DB00627,BE0001042,Solute carrier organic anion transporter family member 2B1,https://www.drugbank.ca/bio_entities/BE0001042,O94956,Solute carrier organic anion transporter family member 2B1 ,11309.0,SLCO2B1,9606.0,Homo sapiens (human),Inhibitor,,,PMID:12724351,https://www.ncbi.nlm.nih.gov/pubmed/12724351,12724351,,"Kobayashi D, Nozawa T, Imai K, Nezu J, Tsuji A, Tamai I: Involvement of human organic anion transporting polypeptide OATP-B (SLC21A9) in pH-dependent transport across intestinal apical membrane. J Pharmacol Exp Ther. 2003 Aug;306(2):703-8. Epub 2003 Apr 30."
273,278991,938,DrugBank,Nicotinic acid,DB00627,Niacin,https://www.drugbank.ca/drugs/DB00627,BE0000669,Monocarboxylate transporter 1,https://www.drugbank.ca/bio_entities/BE0000669,P53985,Monocarboxylate transporter 1,6566.0,SLC16A1,9606.0,Homo sapiens (human),Substrate,,,PMID:10579682|PMID:21741392,https://www.ncbi.nlm.nih.gov/pubmed/10579682|https://www.ncbi.nlm.nih.gov/pubmed/21741392,10579682|21741392,,"Tamai I, Sai Y, Ono A, Kido Y, Yabuuchi H, Takanaga H, Satoh E, Ogihara T, Amano O, Izeki S, Tsuji A: Immunohistochemical and functional characterization of pH-dependent intestinal absorption of weak organic acids by the monocarboxylic acid transporter MCT1. J Pharm Pharmacol. 1999 Oct;51(10):1113-21.|Tachikawa M, Murakami K, Martin PM, Hosoya K, Ganapathy V: Retinal transfer of nicotinate by H+ -monocarboxylate transporter at the inner blood-retinal barrier. Microvasc Res. 2011 Nov;82(3):385-90. doi: 10.1016/j.mvr.2011.06.009. Epub 2011 Jun 29."
274,279459,938,DrugBank,Nicotinic acid,DB00627,Niacin,https://www.drugbank.ca/drugs/DB00627,BE0004708,Sodium-coupled monocarboxylate transporter 1,https://www.drugbank.ca/bio_entities/BE0004708,Q8N695,Sodium-coupled monocarboxylate transporter 1,160728.0,SLC5A8,9606.0,Homo sapiens (human),,,,PMID:15651982,https://www.ncbi.nlm.nih.gov/pubmed/15651982,15651982,,"Gopal E, Fei YJ, Miyauchi S, Zhuang L, Prasad PD, Ganapathy V: Sodium-coupled and electrogenic transport of B-complex vitamin nicotinic acid by slc5a8, a member of the Na/glucose co-transporter gene family. Biochem J. 2005 May 15;388(Pt 1):309-16."
275,279460,938,DrugBank,Nicotinic acid,DB00627,Niacin,https://www.drugbank.ca/drugs/DB00627,BE0000449,Monocarboxylate transporter 4,https://www.drugbank.ca/bio_entities/BE0000449,O15427,Monocarboxylate transporter 4,9123.0,SLC16A3,9606.0,Homo sapiens (human),,,,PMID:16213084,https://www.ncbi.nlm.nih.gov/pubmed/16213084,16213084,,"Shimada A, Nakagawa Y, Morishige H, Yamamoto A, Fujita T: Functional characteristics of H+ -dependent nicotinate transport in primary cultures of astrocytes from rat cerebral cortex. Neurosci Lett. 2006 Jan 16;392(3):207-12. Epub 2005 Oct 5."
276,279461,938,DrugBank,Nicotinic acid,DB00627,Niacin,https://www.drugbank.ca/drugs/DB00627,BE0000537,Thyroxine-binding globulin,https://www.drugbank.ca/bio_entities/BE0000537,P05543,Thyroxine-binding globulin,6906.0,SERPINA7,9606.0,Homo sapiens (human),Inhibitor,,,PMID:7776715|PMID:1405773,https://www.ncbi.nlm.nih.gov/pubmed/7776715|https://www.ncbi.nlm.nih.gov/pubmed/1405773,7776715|1405773,,"Shakir KM, Kroll S, Aprill BS, Drake AJ 3rd, Eisold JF: Nicotinic acid decreases serum thyroid hormone levels while maintaining a euthyroid state. Mayo Clin Proc. 1995 Jun;70(6):556-8. doi: 10.4065/70.6.556.|O'Brien T, Silverberg JD, Nguyen TT: Nicotinic acid-induced toxicity associated with cytopenia and decreased levels of thyroxine-binding globulin. Mayo Clin Proc. 1992 May;67(5):465-8. doi: 10.1016/s0025-6196(12)60393-0."
277,279462,938,DrugBank,Nicotinic acid,DB00627,Niacin,https://www.drugbank.ca/drugs/DB00627,BE0000836,Hydroxycarboxylic acid receptor 3,https://www.drugbank.ca/bio_entities/BE0000836,P49019,Hydroxycarboxylic acid receptor 3,8843.0,HCAR3,9606.0,Homo sapiens (human),Agonist,,,PMID:12563315|PMID:15929991|PMID:16018973|PMID:16099840|PMID:16322797|PMID:12522134,https://www.ncbi.nlm.nih.gov/pubmed/12563315|https://www.ncbi.nlm.nih.gov/pubmed/15929991|https://www.ncbi.nlm.nih.gov/pubmed/16018973|https://www.ncbi.nlm.nih.gov/pubmed/16099840|https://www.ncbi.nlm.nih.gov/pubmed/16322797|https://www.ncbi.nlm.nih.gov/pubmed/12522134,12563315|15929991|16018973|16099840|16322797|12522134,,"Tunaru S, Kero J, Schaub A, Wufka C, Blaukat A, Pfeffer K, Offermanns S: PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect. Nat Med. 2003 Mar;9(3):352-5. Epub 2003 Feb 3.|Taggart AK, Kero J, Gan X, Cai TQ, Cheng K, Ippolito M, Ren N, Kaplan R, Wu K, Wu TJ, Jin L, Liaw C, Chen R, Richman J, Connolly D, Offermanns S, Wright SD, Waters MG: (D)-beta-Hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G. J Biol Chem. 2005 Jul 22;280(29):26649-52. Epub 2005 Jun 1.|Zhang Y, Schmidt RJ, Foxworthy P, Emkey R, Oler JK, Large TH, Wang H, Su EW, Mosior MK, Eacho PI, Cao G: Niacin mediates lipolysis in adipose tissue through its G-protein coupled receptor HM74A. Biochem Biophys Res Commun. 2005 Aug 26;334(2):729-32.|Tunaru S, Lattig J, Kero J, Krause G, Offermanns S: Characterization of determinants of ligand binding to the nicotinic acid receptor GPR109A (HM74A/PUMA-G). Mol Pharmacol. 2005 Nov;68(5):1271-80. Epub 2005 Aug 11.|Benyo Z, Gille A, Kero J, Csiky M, Suchankova MC, Nusing RM, Moers A, Pfeffer K, Offermanns S: GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing. J Clin Invest. 2005 Dec;115(12):3634-40.|Wise A, Foord SM, Fraser NJ, Barnes AA, Elshourbagy N, Eilert M, Ignar DM, Murdock PR, Steplewski K, Green A, Brown AJ, Dowell SJ, Szekeres PG, Hassall DG, Marshall FH, Wilson S, Pike NB: Molecular identification of high and low affinity receptors for nicotinic acid. J Biol Chem. 2003 Mar 14;278(11):9869-74. Epub 2003 Jan 9."
278,370404,938,BindingDB,Nicotinic acid,23515,CHEMBL573,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23515,2411,Hydroxycarboxylic acid receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2411,Q8TDS4,Hydroxycarboxylic acid receptor 2,338442.0,HCAR2,9606.0,Homo sapiens (human),,IC50 (nM),140,PMID:17994679,https://www.ncbi.nlm.nih.gov/pubmed/17994679,17994679,,
279,370405,938,Drug Gene Interaction database (DGIdb),Nicotinic acid,,NIACIN,https://www.dgidb.org/drugs/NIACIN,,CYP2C19,https://www.dgidb.org/genes/CYP2C19,,,1557.0,CYP2C19,9606.0,Homo sapiens (human),,,,PMID:22931300,https://www.ncbi.nlm.nih.gov/pubmed/22931300,22931300,,
